{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":57,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":57,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"f341d2f9e313","filters":{"venue":"Clinical Pharmacology in Drug Development"}},"results":[{"id":"W3011153961","doi":"10.1002/cpdd.789","title":"The Bioequivalence of Tafamidis 61‐mg Free Acid Capsules and Tafamidis Meglumine 4 × 20‐mg Capsules in Healthy Volunteers","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Pfizer","keywords":"Medicine; Bioequivalence; Dosing; Tolerability; Pharmacology; Crossover study; Pharmacokinetics; Internal medicine; Placebo; Adverse effect","authors":[{"name":"Peter Lockwood","is_ca":false},{"name":"Vu Le","is_ca":false},{"name":"Melissa O’Gorman","is_ca":false},{"name":"Terrell A. Patterson","is_ca":false},{"name":"Marla B. Sultan","is_ca":false},{"name":"Ekaterina Tankisheva","is_ca":false},{"name":"Qiang Wang","is_ca":false},{"name":"Steve Riley","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03342460266546551,"gpt":0.3503987466890036,"spread":0.3169741440235381,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001009122,0.0003614893,0.0006361936,0.0000803817,0.0001491756,0.00001756164,0.0007296139,0.000275944,0.00004230254],"category_scores_gemma":[0.0008066013,0.0002922727,0.000129318,0.000253243,0.0009866236,0.00001192722,0.0007702891,0.0003928831,0.00001882156],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009103434,"about_ca_system_score_gemma":0.0005288241,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001178828,"about_ca_topic_score_gemma":0.001177362,"domain_scores_codex":[0.9964782,0.0004715686,0.001410509,0.000828423,0.0002154058,0.0005959192],"domain_scores_gemma":[0.9984875,0.0004439456,0.0003283439,0.0003585527,0.00008689873,0.0002947252],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002522888,0.001644778,0.735567,0.0002832057,0.0008525988,0.0001239622,0.002630797,0.00009815617,0.1681779,0.00006954217,0.07472503,0.01330406],"study_design_scores_gemma":[0.01498827,0.001302982,0.4660999,0.0001085838,0.0001898277,0.00001274214,0.001832218,0.0002788506,0.415945,0.0001098471,0.09806419,0.001067532],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9741971,0.00786507,0.00002057316,0.01649688,0.00062183,0.0006432739,0.00005473724,0.00001906211,0.0000814849],"genre_scores_gemma":[0.9799564,0.0130269,0.001246368,0.005106601,0.0001791278,0.0002534422,0.0000653969,0.00003339873,0.0001323212],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2694671,"threshold_uncertainty_score":0.9999529,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2793257861","doi":"10.1002/cpdd.439","title":"Systemic Pharmacokinetics, Safety, and Preliminary Efficacy of Topical AhR Agonist Tapinarof: Results of a Phase 1 Study","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Innovaderm (Canada)","funders":"GlaxoSmithKline","keywords":"Medicine; Tolerability; Pharmacokinetics; Nonsteroidal; Atopic dermatitis; Incidence (geometry); Cohort; Adverse effect; Safety profile; Open label; Pharmacology; Dermatology; Internal medicine","authors":[{"name":"Robert Bissonnette","is_ca":true},{"name":"Lakshmi Vasist","is_ca":false},{"name":"Jonathan Bullman","is_ca":false},{"name":"Therese Collingwood","is_ca":false},{"name":"Geng Chen","is_ca":false},{"name":"Tomoko Maeda‐Chubachi","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0443249687538772,"gpt":0.4239657936168991,"spread":0.3796408248630219,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001260473,0.0002208208,0.0009720639,0.0001742922,0.00007191567,0.000002636174,0.0002242743,0.000165959,0.00012385],"category_scores_gemma":[0.0005793644,0.0001931716,0.00009390002,0.000204833,0.001192688,0.00003424748,0.0002821543,0.0003773131,0.00002111796],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005408663,"about_ca_system_score_gemma":0.0004234234,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001003489,"about_ca_topic_score_gemma":0.000006087994,"domain_scores_codex":[0.9961643,0.0005861406,0.00220761,0.000514509,0.0002207701,0.0003066305],"domain_scores_gemma":[0.9976533,0.001247708,0.0003983435,0.0002542932,0.0001979816,0.0002483693],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1312719,0.04707219,0.6948502,0.001059692,0.001746206,0.001994508,0.01237836,0.000008557161,0.005722956,0.00001903136,0.06714465,0.03673174],"study_design_scores_gemma":[0.07894621,0.003382866,0.8885295,0.0003671765,0.000709124,0.0002070693,0.0008421693,0.0002219957,0.0201107,0.00001753016,0.006393707,0.0002719747],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949939,0.0006590399,0.00001818943,0.0009004054,0.00113665,0.001355902,0.0000166926,0.00003069731,0.0008885194],"genre_scores_gemma":[0.998165,0.0002672395,0.000436157,0.0004989507,0.0002321783,0.00004125258,0.00002511665,0.00001522478,0.0003189427],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1936793,"threshold_uncertainty_score":0.7877309,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2889013879","doi":"10.1002/cpdd.608","title":"Pharmacokinetics and Comparative Bioavailability of a Levothyroxine Sodium Oral Solution and Soft Capsule","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"Levothyroxine; Bioequivalence; Medicine; Bioavailability; Pharmacokinetics; Crossover study; Randomization; Capsule; Oral administration; Dosage form; Pharmacology; Internal medicine; Randomized controlled trial; Placebo; Hormone","authors":[{"name":"Mario Tanguay","is_ca":true},{"name":"Johanne Girard","is_ca":false},{"name":"Claudia Scarsi","is_ca":false},{"name":"Giuseppe Mautone","is_ca":false},{"name":"Richard Larouche","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2020510462544798,"gpt":0.4820193330155821,"spread":0.2799682867611023,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001687351,0.0001862535,0.0006491588,0.00006990647,0.0001118667,0.000006082998,0.00007894027,0.0001044663,0.0003321394],"category_scores_gemma":[0.0002213859,0.0001537072,0.00003984026,0.0001762739,0.001600468,0.0000768391,0.0002743087,0.0004487148,0.00002544425],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005943277,"about_ca_system_score_gemma":0.0001548087,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004050439,"about_ca_topic_score_gemma":0.0000694697,"domain_scores_codex":[0.9979347,0.0003125934,0.0008741593,0.0004219289,0.0001360507,0.000320544],"domain_scores_gemma":[0.9985381,0.0007359753,0.0001994418,0.00008867092,0.0001885217,0.0002492836],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01070606,0.007376102,0.5903697,0.0009715133,0.002170697,0.0001311751,0.01165976,0.000002972913,0.1296223,0.0001332532,0.11759,0.1292665],"study_design_scores_gemma":[0.01365355,0.0008235376,0.544937,0.00007427006,0.0004839613,0.00003505873,0.0003933152,0.003015032,0.1184097,0.0001261471,0.3176675,0.0003809417],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905738,0.001602705,0.00005271309,0.005376148,0.0007382439,0.0005364764,0.000005737958,0.00002338335,0.001090782],"genre_scores_gemma":[0.9919336,0.001324847,0.003642014,0.002614183,0.0002456032,0.00002768583,0.000005342544,0.000007220977,0.0001994899],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2000775,"threshold_uncertainty_score":0.6267996,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2766447985","doi":"10.1002/cpdd.395","title":"Pharmacokinetics of the BCL‐2 Inhibitor Venetoclax in Healthy Chinese Subjects","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Genentech; AbbVie","keywords":"Venetoclax; Medicine; Pharmacokinetics; Pharmacology; Internal medicine; Oncology; Leukemia","authors":[{"name":"TT Cheung","is_ca":false},{"name":"Ahmed Hamed Salem","is_ca":false},{"name":"Rajeev Menon","is_ca":false},{"name":"Wijith Munasinghe","is_ca":false},{"name":"Orlando F. Bueno","is_ca":false},{"name":"Suresh Agarwal","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05623555057927133,"gpt":0.4560224450009049,"spread":0.3997868944216336,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00251523,0.0002365794,0.0007383822,0.0001715746,0.0001513983,0.00001228543,0.0008535559,0.0002157157,0.0001920406],"category_scores_gemma":[0.001215184,0.0001663607,0.0001407926,0.0002804299,0.0007929633,0.00006555559,0.0008368018,0.001136066,0.00005976402],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.006164319,"about_ca_system_score_gemma":0.01573622,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002638483,"about_ca_topic_score_gemma":0.0004520567,"domain_scores_codex":[0.996489,0.0004013752,0.001477657,0.0005112602,0.0004863599,0.0006343667],"domain_scores_gemma":[0.9977057,0.0008158978,0.0004189145,0.0006601953,0.0001270087,0.0002723001],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006809531,0.002425939,0.9372243,0.0007943606,0.000273298,0.0009427112,0.002439861,0.0003033687,0.004879142,0.00001808759,0.02713911,0.0167503],"study_design_scores_gemma":[0.05829802,0.0001946715,0.9026196,0.000289353,0.00004502351,0.00004264705,0.00003693143,0.003059965,0.01728242,0.00008107896,0.01780679,0.0002435288],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9889098,0.0003522294,0.000001309311,0.004923899,0.003257815,0.00126217,0.000002677577,0.00001696611,0.001273145],"genre_scores_gemma":[0.9951089,0.0005686301,0.0003762248,0.002596261,0.0005432598,0.0001188532,0.000004677248,0.00002905383,0.000654134],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05148849,"threshold_uncertainty_score":0.9976509,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2606334551","doi":"10.1002/cpdd.358","title":"Single‐ and Multiple‐Dose Pharmacokinetics of Once‐Daily Formulations of Raltegravir","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Pharma Medica Research (Canada)","funders":"Merck","keywords":"Raltegravir; Pharmacokinetics; Bioavailability; Pharmacology; Medicine; Biopharmaceutics; Dosing; Biopharmaceutics Classification System; In vivo; Human immunodeficiency virus (HIV); Chemistry; Virology; Antiretroviral therapy; In vitro; Biological activity; Biology; Viral load; Biochemistry; Pharmacognosy; Biotechnology","authors":[{"name":"Rajesh Krishna","is_ca":false},{"name":"Matthew L. Rizk","is_ca":false},{"name":"Patrick Larson","is_ca":false},{"name":"Valerie Schulz","is_ca":false},{"name":"Filippos Kesisoglou","is_ca":false},{"name":"Radu Pop","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08495309511939617,"gpt":0.4174303690147653,"spread":0.3324772738953691,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008348278,0.0002464436,0.0008052657,0.0002030034,0.000147403,0.000009388248,0.0002451532,0.0001471919,0.0001379385],"category_scores_gemma":[0.0003655844,0.0002124006,0.0001159938,0.0001056676,0.000590464,0.000101134,0.0002585744,0.0003261893,0.00001828972],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001033578,"about_ca_system_score_gemma":0.0004081024,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001547628,"about_ca_topic_score_gemma":0.00004154088,"domain_scores_codex":[0.9974546,0.0001094915,0.001458022,0.0003958525,0.0002521917,0.0003298877],"domain_scores_gemma":[0.9980251,0.0006594227,0.0005999003,0.0003062768,0.0001779999,0.0002313529],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001021389,0.003355348,0.9116704,0.0002224362,0.0006664721,0.0001249954,0.002315409,0.00001118167,0.01380762,0.00007068578,0.00622914,0.06050496],"study_design_scores_gemma":[0.01976175,0.0001648246,0.8449247,0.0002302719,0.0003327226,0.00001313244,0.0001168135,0.0006442402,0.1053385,0.0001299676,0.0280559,0.0002871191],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934002,0.0002124469,0.00002442036,0.00278382,0.0006740497,0.0007805535,0.000009397805,0.00002200989,0.002093113],"genre_scores_gemma":[0.9805075,0.0004677389,0.01590535,0.0002694845,0.0001005241,0.00003786967,0.00003081134,0.0000218771,0.002658838],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09153087,"threshold_uncertainty_score":0.8661444,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4293367557","doi":"10.1002/cpdd.1153","title":"Bioequivalence and Relative Bioavailability Studies to Assess a New Acalabrutinib Formulation That Enables Coadministration With Proton‐Pump Inhibitors","year":2022,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Bioavailability; Pharmacokinetics; Medicine; Pharmacology; Tolerability; Bioequivalence; Chemistry; Adverse effect","authors":[{"name":"Shringi Sharma","is_ca":false},{"name":"Xavier Pépin","is_ca":false},{"name":"Haran Burri","is_ca":false},{"name":"Lianqing Zheng","is_ca":false},{"name":"Nataliya Kuptsova‐Clarkson","is_ca":false},{"name":"Anouk de Jong","is_ca":false},{"name":"Ting Yu","is_ca":false},{"name":"Holly L. MacArthur","is_ca":true},{"name":"Michał Majewski","is_ca":true},{"name":"John C. Byrd","is_ca":false},{"name":"Richard R. Furman","is_ca":false},{"name":"Joseph A. Ware","is_ca":false},{"name":"James Mann","is_ca":false},{"name":"David A. Ramies","is_ca":false},{"name":"Veerendra Munugalavadla","is_ca":false},{"name":"Louise Sheridan","is_ca":false},{"name":"Helen Tomkinson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2395849207718664,"gpt":0.4805594073694024,"spread":0.240974486597536,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003150539,0.0002271638,0.0005456663,0.0001971038,0.0002532387,0.00001542006,0.0001636072,0.00009876618,0.0001972898],"category_scores_gemma":[0.0007162066,0.0001843022,0.00004310423,0.0005299061,0.0003590231,0.00016444,0.0006084793,0.0007143082,0.00001888156],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.006628006,"about_ca_system_score_gemma":0.01032065,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006288689,"about_ca_topic_score_gemma":0.00008921944,"domain_scores_codex":[0.9967754,0.0005264098,0.0009037188,0.0007415941,0.0006028781,0.0004500318],"domain_scores_gemma":[0.9974825,0.001598623,0.0002041392,0.0001998528,0.0001629084,0.0003519682],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01829172,0.003574937,0.8743407,0.001631671,0.001635657,0.001127161,0.03122099,0.000482438,0.004071472,0.0002611229,0.0348546,0.02850752],"study_design_scores_gemma":[0.1237467,0.008438784,0.451172,0.001042578,0.0007195319,0.0005635032,0.01603118,0.004499055,0.2250657,0.001342879,0.16527,0.002108238],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892536,0.000260457,0.00008260399,0.005980874,0.0004331641,0.003771568,0.000004067482,0.00005308372,0.0001605279],"genre_scores_gemma":[0.992294,0.0001585017,0.003702515,0.001327247,0.0001368934,0.001159837,0.00002301397,0.00002041911,0.001177573],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4231687,"threshold_uncertainty_score":0.9971853,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2347141072","doi":"10.1002/cpdd.269","title":"Confirmation of Biosimilarity in a Pharmacokinetic/Pharmacodynamic Study in Healthy Volunteers for an Analytically Highly Similar Pegfilgrastim","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Apotex (Canada)","funders":"","keywords":"Pegfilgrastim; Medicine; Biosimilar; Confidence interval; Pharmacodynamics; Pharmacokinetics; Crossover study; Bioequivalence; Clinical endpoint; Internal medicine; Pharmacology; Surrogate endpoint; Filgrastim; Randomized controlled trial; Granulocyte colony-stimulating factor; Placebo; Chemotherapy","authors":[{"name":"Kalpna Desai","is_ca":true},{"name":"Tina Catalano","is_ca":true},{"name":"Gurinder Rai","is_ca":true},{"name":"Priya Misra","is_ca":true},{"name":"Nirmesh Shah","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08186570106038771,"gpt":0.4648163808401086,"spread":0.3829506797797209,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002528902,0.0002703535,0.0009019008,0.0006322056,0.00004727897,0.000005359854,0.0002399913,0.0001567169,0.0002700104],"category_scores_gemma":[0.0001843675,0.0002203577,0.0001122058,0.000599411,0.0002334845,0.0001430176,0.00008698604,0.0005281629,0.00001639312],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00057254,"about_ca_system_score_gemma":0.0009274923,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001093657,"about_ca_topic_score_gemma":0.001432873,"domain_scores_codex":[0.9958225,0.0005843019,0.002135248,0.0006622326,0.0002537882,0.0005419224],"domain_scores_gemma":[0.9981661,0.0008933129,0.0002455475,0.0001983736,0.0002039972,0.0002926004],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01012809,0.01157716,0.9390546,0.0002523747,0.000254566,0.0001083641,0.001190056,0.0002612197,0.01968804,0.00002260939,0.004343506,0.01311942],"study_design_scores_gemma":[0.04646017,0.002112876,0.9357362,0.0001867314,0.0002269398,0.000008501203,0.0002681562,0.003262028,0.006385911,0.00007129095,0.004920523,0.0003606888],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9876732,0.00004543338,0.0002783784,0.007417152,0.001189943,0.003168366,0.00002233292,0.00004005358,0.0001650953],"genre_scores_gemma":[0.994323,0.0001998011,0.0009220624,0.003633092,0.0001349499,0.0006734578,0.00002041482,0.00002821504,0.00006507494],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03633208,"threshold_uncertainty_score":0.8985926,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3120034421","doi":"10.1002/cpdd.904","title":"Pharmacokinetics and Safety of PTC596, a Novel Tubulin‐Binding Agent, in Subjects With Advanced Solid Tumors","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"PTC Therapeutics","keywords":"Medicine; Pharmacokinetics; Tubulin; Pharmacology; Microtubule","authors":[{"name":"Geoffrey I. Shapiro","is_ca":false},{"name":"Edward O’Mara","is_ca":false},{"name":"Oscar L. Laskin","is_ca":false},{"name":"Lan Gao","is_ca":false},{"name":"John D. Baird","is_ca":false},{"name":"Robert J. Spiegel","is_ca":false},{"name":"Diksha Kaushik","is_ca":false},{"name":"Marla Weetall","is_ca":false},{"name":"Joseph M. Colacino","is_ca":false},{"name":"Kylie O’Keefe","is_ca":false},{"name":"Arthur Branstrom","is_ca":false},{"name":"Elizabeth Goodwin","is_ca":false},{"name":"Jeffrey R. Infante","is_ca":false},{"name":"Philippe L. Bédard","is_ca":true},{"name":"Ronald Kong","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02767090759368996,"gpt":0.3555511339723538,"spread":0.3278802263786638,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006010041,0.0001956562,0.0004074992,0.0000755749,0.00003722989,0.000005818614,0.0001520941,0.0001276776,0.00004303824],"category_scores_gemma":[0.00004033438,0.000192519,0.00004900409,0.0001958225,0.0001399099,0.000004487369,0.0002267821,0.000274826,0.000001761577],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005173458,"about_ca_system_score_gemma":0.0005583438,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003954759,"about_ca_topic_score_gemma":0.000173852,"domain_scores_codex":[0.9981228,0.0001144464,0.0007853314,0.0005198211,0.0001171938,0.0003403914],"domain_scores_gemma":[0.9993792,0.00008528004,0.0001799987,0.0001417619,0.0000921602,0.0001215919],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001254615,0.0006598904,0.01002164,0.00006704234,0.0001782969,0.0001068697,0.0004009986,0.0004641323,0.9745402,0.00002745672,0.0001765341,0.01210233],"study_design_scores_gemma":[0.008845712,0.0002023489,0.01530112,0.00009646135,0.00003717258,0.00002956101,0.0001831744,0.000119585,0.95083,0.00002497745,0.02402559,0.0003043243],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975089,0.0006443252,0.0004196724,0.0002738697,0.0005982952,0.0003084305,0.00001154159,0.000005945808,0.000228986],"genre_scores_gemma":[0.9900283,0.002556,0.005574243,0.001358554,0.0000947131,0.00005380832,0.00005157201,0.00002502162,0.0002577733],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02384906,"threshold_uncertainty_score":0.7850698,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3091934681","doi":"10.1002/cpdd.871","title":"Biopharmaceutical Characteristics of Nifurtimox Tablets for Age‐ and Body Weight‐Adjusted Dosing in Patients With Chagas Disease","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Trypanosoma species research and implications","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"Bayer","keywords":"Bioequivalence; Cmax; Medicine; Dosing; Bioavailability; Pharmacology; Confidence interval; Pharmacokinetics; Internal medicine","authors":[{"name":"Heino Staß","is_ca":false},{"name":"Ethel Feleder","is_ca":false},{"name":"Facundo García‐Bournissen","is_ca":true},{"name":"Johannes Nagelschmitz","is_ca":false},{"name":"Boris Weimann","is_ca":false},{"name":"G. Yerino","is_ca":false},{"name":"Jaime Altcheh","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06803022149680939,"gpt":0.3917060144841638,"spread":0.3236757929873544,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001382432,0.0001635643,0.0005203006,0.0001272017,0.00004787107,0.000007991903,0.0001253551,0.00008235797,0.0001104207],"category_scores_gemma":[0.0004558924,0.0001355808,0.00004325563,0.000287955,0.0003228824,0.00005951188,0.0001340755,0.0004120001,0.0000094064],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000862367,"about_ca_system_score_gemma":0.0004383686,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002279672,"about_ca_topic_score_gemma":0.000002608147,"domain_scores_codex":[0.9979792,0.0001077782,0.0008924161,0.0004116551,0.0002102505,0.0003987301],"domain_scores_gemma":[0.998512,0.0004397316,0.0001315678,0.0001100104,0.0001438053,0.0006628918],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007902834,0.002189863,0.9722782,0.0004268291,0.0001546052,0.0001586436,0.000389991,9.717015e-7,0.004999546,0.00004176013,0.003296156,0.008160586],"study_design_scores_gemma":[0.01145908,0.0002764646,0.9757112,0.00007953273,0.00007702888,8.026161e-7,0.00001826664,0.0005583867,0.0009771977,0.000008859201,0.01069587,0.0001373426],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9901762,0.0000766727,0.00007529653,0.00791691,0.0001638536,0.001479081,0.00004683195,0.00002023066,0.00004492293],"genre_scores_gemma":[0.9941535,0.0001611206,0.002232943,0.002933766,0.0001378386,0.0001617122,0.0001489777,0.00002039498,0.00004977786],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008023244,"threshold_uncertainty_score":0.5528823,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3113925818","doi":"10.1002/cpdd.894","title":"Comparison of Steroidogenic Exposure Following the Administration of Repository Corticotropin Injection With a Synthetic ACTH<sub>1‐24</sub> Depot and Methylprednisolone in Healthy Subjects","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Adrenal Hormones and Disorders","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medicine; Depot; Prednisone; Methylprednisolone; Internal medicine; Pharmacodynamics; Subcutaneous injection; Pharmacokinetics; Adrenocorticotropic hormone; Endocrinology; Pharmacology; Hormone","authors":[{"name":"Xiaofeng Wang","is_ca":false},{"name":"Loan Pham","is_ca":false},{"name":"Nagaraju Poola","is_ca":false},{"name":"Leah R. Brooks","is_ca":false},{"name":"Bryan Due","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05146719463994026,"gpt":0.3778594674939645,"spread":0.3263922728540242,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003920746,0.0001493019,0.0006461662,0.00008006497,0.00004922879,0.000003640766,0.00008468246,0.0001196821,0.000003355931],"category_scores_gemma":[0.0001483558,0.0001108585,0.00007020837,0.0002727719,0.0001926431,0.00004423248,0.00005948417,0.0004255118,9.608232e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000598023,"about_ca_system_score_gemma":0.0005146951,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002155582,"about_ca_topic_score_gemma":0.0002008131,"domain_scores_codex":[0.9976187,0.000351369,0.001297558,0.0003228677,0.0002064177,0.0002030562],"domain_scores_gemma":[0.9987876,0.0005242668,0.0003978558,0.0001046774,0.00004985202,0.0001356811],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02245338,0.001829695,0.8469501,0.000436072,0.0003773191,0.0001797443,0.008880993,0.0002838229,0.1076362,0.000003417335,0.0002751025,0.01069416],"study_design_scores_gemma":[0.008025154,0.004799666,0.7383403,0.0001971956,0.0002823442,0.00005120114,0.002629342,0.001023971,0.2444114,0.000009346902,0.00004241507,0.0001876989],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995618,0.001395796,0.0001228357,0.001855114,0.0002710721,0.0006961395,6.917637e-7,0.00001362375,0.00002666869],"genre_scores_gemma":[0.9985664,0.0001553147,0.0004494211,0.0007100989,0.00004138689,0.00005452728,0.000006628882,0.00001313337,0.000003084557],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1367752,"threshold_uncertainty_score":0.4520679,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3200515041","doi":"10.1002/cpdd.1020","title":"Pharmacokinetics and Pharmacodynamics of Repository Corticotropin Injection Compared With Synthetic ACTH<sub>1‐24</sub> Depot and Methylprednisolone in Healthy Subjects","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Adrenal Hormones and Disorders","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Depot; Medicine; Pharmacodynamics; Adrenocorticotropic hormone; Pharmacokinetics; Methylprednisolone; Internal medicine; Endocrinology; Corticosteroid; Pharmacology; Hormone","authors":[{"name":"Nagaraju Poola","is_ca":false},{"name":"Bryan Due","is_ca":false},{"name":"Dale Wright","is_ca":false},{"name":"Leah R. Brooks","is_ca":false},{"name":"Fahima Zaman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02523109182896986,"gpt":0.3414021503317863,"spread":0.3161710585028165,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004339545,0.0002610242,0.0008486836,0.0002126052,0.00007048041,0.000008494138,0.0000762868,0.0001550162,0.00001444726],"category_scores_gemma":[0.0001034954,0.0002431556,0.00005097669,0.0004036846,0.0004168036,0.00006296795,0.000150338,0.0006674669,0.000001703085],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001416794,"about_ca_system_score_gemma":0.0006965545,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004195518,"about_ca_topic_score_gemma":0.0002374144,"domain_scores_codex":[0.9970416,0.0004090831,0.001324358,0.0005988275,0.0002302598,0.0003958932],"domain_scores_gemma":[0.9984842,0.0006183069,0.0003135881,0.0001401289,0.0001480677,0.0002957217],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01865319,0.005408496,0.6483202,0.001325763,0.0008170546,0.002567146,0.00324498,0.0009189277,0.2807113,0.0000146888,0.00124201,0.0367763],"study_design_scores_gemma":[0.02799446,0.001176435,0.6646044,0.0004078546,0.0005794731,0.0008544729,0.001057367,0.00894984,0.2932252,0.0000469666,0.0005190512,0.0005844718],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994293,0.003194841,0.0001237779,0.0009997599,0.0006389996,0.0006085321,0.000003110183,0.00002889238,0.0001090933],"genre_scores_gemma":[0.9919766,0.004738957,0.001725542,0.001349745,0.00006692073,0.0000611526,0.00002344442,0.00002875126,0.00002888666],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03619183,"threshold_uncertainty_score":0.9915598,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2807342171","doi":"10.1002/cpdd.471","title":"Pharmacokinetic Characteristics of Tofacitinib in Adult Patients With Moderate to Severe Chronic Plaque Psoriasis","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University; Probity Medical Research","funders":"Pfizer","keywords":"Janus kinase inhibitor; Medicine; Tofacitinib; Dosing; Pharmacokinetics; Psoriasis; Volume of distribution; Renal function; Plaque psoriasis; Internal medicine; Body surface area; Creatinine; Body mass index; Clearance; Gastroenterology; Pharmacology; Urology; Immunology; Rheumatoid arthritis","authors":[{"name":"Guangli Ma","is_ca":false},{"name":"Rujia Xie","is_ca":false},{"name":"Bruce Strober","is_ca":true},{"name":"Richard G. Langley","is_ca":true},{"name":"Kaori Ito","is_ca":false},{"name":"Sriram Krishnaswami","is_ca":false},{"name":"Robert Wołk","is_ca":false},{"name":"Hernán Valdez","is_ca":false},{"name":"Scott T. Rottinghaus","is_ca":false},{"name":"Anna M. Tallman","is_ca":false},{"name":"Pankaj Gupta","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01935625667845373,"gpt":0.303296412492652,"spread":0.2839401558141982,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005469897,0.0003503604,0.0007891956,0.0002850083,0.00008922514,0.000005679784,0.0003568054,0.0002879025,0.001211189],"category_scores_gemma":[0.00008316787,0.0003009705,0.00007168879,0.0003781854,0.0003199645,0.00007325019,0.0001727156,0.0003945204,0.0005152716],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002340576,"about_ca_system_score_gemma":0.0004325058,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002974575,"about_ca_topic_score_gemma":0.0002067825,"domain_scores_codex":[0.9968182,0.0005152404,0.001324262,0.0006317553,0.00008071311,0.0006298683],"domain_scores_gemma":[0.9987265,0.0004111655,0.0002942708,0.0002045934,0.0002722582,0.00009116808],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01120211,0.003567043,0.7893414,0.00009901635,0.0009792335,0.00006709058,0.003249514,0.00004926739,0.005358486,0.00002314881,0.007379437,0.1786842],"study_design_scores_gemma":[0.02430692,0.0006216537,0.8790224,0.0001628558,0.0001471337,0.000005593285,0.00004895711,0.00001932559,0.07816684,0.00001315316,0.01695555,0.0005295725],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954042,0.0000842966,0.00002145442,0.0003082769,0.002882666,0.0008766422,0.0001148917,0.00003515067,0.0002724615],"genre_scores_gemma":[0.9970595,0.0001484256,0.0005710374,0.001052769,0.0001699131,0.0002359529,0.0002495818,0.00002945759,0.0004833721],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1781547,"threshold_uncertainty_score":0.9999443,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4391745346","doi":"10.1002/cpdd.1379","title":"Safety, Pharmacokinetics, and Pharmacodynamics of Etrasimod: Single and Multiple Ascending Dose Studies in Healthy Adults","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Pfizer","keywords":"Pharmacokinetics; Medicine; Pharmacodynamics; Dosing; Adverse effect; Pharmacology; Discontinuation; Internal medicine; Gastroenterology","authors":[{"name":"Caroline A. Lee","is_ca":false},{"name":"Stefan Schreiber","is_ca":false},{"name":"Brian Bressler","is_ca":true},{"name":"John Adams","is_ca":false},{"name":"D. Alexander Oh","is_ca":false},{"name":"Yong Tang","is_ca":false},{"name":"Jinkun Zhang","is_ca":false},{"name":"Heather Kiyomi Komori","is_ca":false},{"name":"John S. Grundy","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05411766612786526,"gpt":0.4104809408775827,"spread":0.3563632747497174,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001457618,0.0002286551,0.0004666877,0.0001990147,0.00005452168,0.0000109585,0.0001421807,0.0001475817,0.00001282983],"category_scores_gemma":[0.0002145323,0.000222464,0.00005130318,0.0002069292,0.0003378262,0.00001151492,0.0003161487,0.0003695412,0.000001813135],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005097411,"about_ca_system_score_gemma":0.0001562839,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001164313,"about_ca_topic_score_gemma":0.00007700935,"domain_scores_codex":[0.9977062,0.0002473106,0.0009523722,0.0006224613,0.0001126741,0.0003589671],"domain_scores_gemma":[0.9991188,0.0004828053,0.0001111537,0.00009002991,0.00005755448,0.0001396232],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01094448,0.002019693,0.1598315,0.002989594,0.001331534,0.0003317008,0.009169551,0.001139278,0.6446733,0.00008333303,0.006225513,0.1612605],"study_design_scores_gemma":[0.06349117,0.001744893,0.1323651,0.001968712,0.0005292941,0.0001354612,0.004239673,0.0361022,0.5266338,0.0002523282,0.2297298,0.002807518],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9712616,0.02534023,0.00005546119,0.0005226632,0.002382145,0.0003671829,0.00001246613,0.00001694757,0.00004127973],"genre_scores_gemma":[0.974553,0.02286993,0.001391877,0.0007230114,0.0003410446,0.00002484175,0.00002729721,0.00002563792,0.00004339431],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2235043,"threshold_uncertainty_score":0.907182,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2803358008","doi":"10.1002/cpdd.473","title":"Tramadol Hydrochloride at Steady State Lacks Clinically Relevant QTc Interval Increases in Healthy Adults","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Veterinary Pharmacology and Anesthesia","field":"Veterinary","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Tata Consultancy Services; Janssen Research and Development; Janssen Scientific Affairs; Valeant Pharmaceuticals International","keywords":"Medicine; Placebo; Tramadol; QT interval; Anesthesia; Moxifloxacin; Adverse effect; Tramadol Hydrochloride; Crossover study; Nausea; Internal medicine; Analgesic; Antibiotics","authors":[{"name":"Joseph Massarella","is_ca":false},{"name":"Jay Ariyawansa","is_ca":false},{"name":"Jaya Natarajan","is_ca":false},{"name":"Stephan Francke","is_ca":false},{"name":"Thomas Murtaugh","is_ca":false},{"name":"Byron DeLemos","is_ca":false},{"name":"Subusola Vaughan","is_ca":false},{"name":"Sérgio Fonseca","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0815724810782293,"gpt":0.4292402465489839,"spread":0.3476677654707546,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.004088213,0.0006116095,0.001302499,0.0003280216,0.0002403687,0.00001949355,0.00098483,0.0004916586,0.003342278],"category_scores_gemma":[0.0003468906,0.0005981709,0.0002306509,0.0003967297,0.001014536,0.0002403078,0.0009128385,0.001728217,0.003430636],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006143758,"about_ca_system_score_gemma":0.0006338417,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002891787,"about_ca_topic_score_gemma":0.001027326,"domain_scores_codex":[0.990557,0.002362282,0.003924021,0.001546638,0.0003301699,0.001279901],"domain_scores_gemma":[0.9948787,0.003335926,0.0006482131,0.0004237452,0.0001284623,0.0005849571],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3369087,0.01322184,0.5218759,0.000290387,0.0007381693,0.02188929,0.01090711,0.00003240381,0.003886445,0.00001199998,0.05460981,0.03562796],"study_design_scores_gemma":[0.03075188,0.01114621,0.8336703,0.0005562847,0.0001169464,0.0005301947,0.0004985859,0.001510425,0.001762923,0.0003537339,0.1174312,0.001671371],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923449,0.0002009318,0.00001043703,0.002091965,0.003305088,0.001090434,0.00002813668,0.0001897382,0.0007384041],"genre_scores_gemma":[0.9806663,0.0004762332,0.001321569,0.01533388,0.001000857,0.0003372055,0.00006190583,0.00007495424,0.0007271476],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3117944,"threshold_uncertainty_score":0.999647,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2806608475","doi":"10.1002/cpdd.581","title":"Pharmacokinetics of Perampanel in Healthy Korean, White, and Japanese Adult Subjects","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Eisai Canada","keywords":"Medicine; Perampanel; Pharmacokinetics; White (mutation); Pharmacology; Adverse effect; Genetics","authors":[{"name":"Hiroko Tabuchi","is_ca":false},{"name":"Sari Shiba","is_ca":false},{"name":"Sanae Yasuda","is_ca":false},{"name":"Akihiro Ohnishi","is_ca":false},{"name":"Jae‐Gook Shin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05097963392920123,"gpt":0.4227265915702705,"spread":0.3717469576410692,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001227178,0.0002137241,0.000664487,0.0002956899,0.00004643415,0.000004630247,0.0001379817,0.0001476124,0.000461066],"category_scores_gemma":[0.0002904627,0.0001802026,0.00005694382,0.0003728449,0.0006235611,0.00004356059,0.0001613825,0.0005857158,0.00005457224],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001675338,"about_ca_system_score_gemma":0.0006084347,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009708499,"about_ca_topic_score_gemma":0.0004424826,"domain_scores_codex":[0.9971681,0.000333652,0.001159975,0.000499195,0.0002725896,0.0005665352],"domain_scores_gemma":[0.9984049,0.000583788,0.0001374443,0.0001663179,0.0002582089,0.0004493495],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004588477,0.002817086,0.9694949,0.0002158058,0.0001591629,0.0003830184,0.004256655,0.000001603529,0.0009394374,0.000007136809,0.007493276,0.009643438],"study_design_scores_gemma":[0.02082862,0.001636449,0.9626824,0.0001643121,0.0000622275,0.00004266607,0.0004784495,0.000330018,0.01054841,0.00003456291,0.002974849,0.0002170123],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922668,0.0003467211,0.000001560686,0.004262729,0.0005717725,0.0008782487,0.000004133541,0.00002258431,0.001645442],"genre_scores_gemma":[0.9919503,0.001534936,0.001824289,0.00380808,0.0002635272,0.0001043957,0.00002121084,0.0000205084,0.0004727131],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01624014,"threshold_uncertainty_score":0.7348449,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4220822477","doi":"10.1002/cpdd.1089","title":"Effect of Colonic Absorption on the Pharmacokinetic Properties of Delayed‐Release and Extended‐Release Methylphenidate: In Vivo, In Vitro, and Modeling Evaluations","year":2022,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Viron Therapeutics (Canada)","funders":"","keywords":"Pharmacokinetics; Methylphenidate; Bioavailability; Pharmacology; Absorption (acoustics); Morning; Medicine; Crossover study; In vivo; Gastrointestinal tract; Small intestine; Evening; Internal medicine; Attention deficit hyperactivity disorder; Biology; Materials science; Placebo; Psychiatry; Pathology","authors":[{"name":"Bev Incledon","is_ca":false},{"name":"Chantal Incledon","is_ca":false},{"name":"Roberto Goméni","is_ca":false},{"name":"Cassandra Uchida","is_ca":true},{"name":"Amy Morris","is_ca":false},{"name":"Kim Perry","is_ca":false},{"name":"Jill Kapuscinski","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0722415416888,"gpt":0.4134766494053294,"spread":0.3412351077165294,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004086416,0.00017794,0.0005626304,0.0003352394,0.00007271282,0.000003128948,0.0001095148,0.00006945372,0.000287213],"category_scores_gemma":[0.0005228504,0.0001393827,0.00005721762,0.0003706393,0.0002006348,0.00005443636,0.0002054638,0.0007874417,0.000002833147],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001718976,"about_ca_system_score_gemma":0.0003052013,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008077661,"about_ca_topic_score_gemma":0.00003647065,"domain_scores_codex":[0.9965731,0.001443017,0.001053249,0.000380528,0.0003174947,0.0002326035],"domain_scores_gemma":[0.9981993,0.001317221,0.0002128372,0.0001294316,0.00006561511,0.0000755668],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.03014603,0.008339152,0.06332638,0.0009139692,0.0005232478,0.0001457389,0.006261289,0.07403214,0.7647265,0.00003488524,0.0003960056,0.05115465],"study_design_scores_gemma":[0.03680381,0.002231634,0.06473717,0.0003932416,0.000748392,0.00005313796,0.002750968,0.6486887,0.2425975,0.0001297047,0.0002751069,0.0005906523],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954035,0.001011085,0.00001530024,0.001755867,0.0001939588,0.00157805,0.000006609759,0.00001063521,0.00002502392],"genre_scores_gemma":[0.9982042,0.0003632442,0.00009379879,0.0006185622,0.00001619694,0.0006283831,0.000008529502,0.00001763651,0.00004947282],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5746565,"threshold_uncertainty_score":0.568386,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2158520906","doi":"10.1002/cpdd.189","title":"Effect of lapatinib on oral digoxin absorption in patients","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Cancer Foundation","funders":"GlaxoSmithKline","keywords":"Lapatinib; Digoxin; Medicine; Pharmacokinetics; Pharmacology; Therapeutic index; Oral administration; Drug interaction; Metastatic breast cancer; Absorption (acoustics); Concomitant; Breast cancer; Drug; Internal medicine; Cancer; Trastuzumab; Heart failure","authors":[{"name":"Kevin M. Koch","is_ca":false},{"name":"Deborah A. Smith","is_ca":false},{"name":"Jeff Botbyl","is_ca":false},{"name":"Nikita Arya","is_ca":false},{"name":"Linda P. Briley","is_ca":false},{"name":"Leanne Cartee","is_ca":false},{"name":"Jane Holshouser White","is_ca":false},{"name":"J. Beyer","is_ca":false},{"name":"Mohammed M. Dar","is_ca":false},{"name":"Hyun Choel Chung","is_ca":false},{"name":"Quincy S. Chu","is_ca":true},{"name":"Yung‐Jue Bang","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03924627127115151,"gpt":0.3940237622506233,"spread":0.3547774909794718,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00246439,0.0001652346,0.0006178766,0.0001844512,0.00001298524,0.000001569316,0.000109845,0.0001558297,0.00007958749],"category_scores_gemma":[0.0001548412,0.0001267545,0.00007309994,0.0002090788,0.00009414919,0.0000325599,0.00003113782,0.000415954,0.00008012282],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001765967,"about_ca_system_score_gemma":0.000226735,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009621851,"about_ca_topic_score_gemma":0.00004772893,"domain_scores_codex":[0.9978434,0.0003212878,0.0009796969,0.0003046684,0.0002847239,0.0002662112],"domain_scores_gemma":[0.9991815,0.0003039959,0.0001454277,0.0001125187,0.00007228422,0.0001842662],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007535326,0.002376806,0.9647061,0.0001326757,0.00005635072,0.00008731573,0.000651608,0.00004158835,0.0002713547,0.00001363005,0.003348849,0.02077844],"study_design_scores_gemma":[0.0272383,0.00173578,0.9270819,0.0002199392,0.00005478851,5.605851e-7,0.00003281279,0.00004730196,0.03870868,0.00004162133,0.004662498,0.0001758468],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962016,0.00002464226,0.000006852828,0.0003005092,0.00172689,0.000758482,0.000001883859,0.00002211106,0.000957005],"genre_scores_gemma":[0.9982917,0.00002051054,0.0004733921,0.0006516244,0.00006579846,0.00006748419,0.00005035223,0.00001523324,0.0003639055],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03843732,"threshold_uncertainty_score":0.5168897,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2945178990","doi":"10.1002/cpdd.699","title":"Evaluation of the Pharmacokinetic Interaction Between Doravirine and Methadone","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Pharma Medica Research (Canada)","funders":"","keywords":"Methadone; Medicine; Pharmacokinetics; Dosing; Confidence interval; Pharmacology; Drug interaction; Methadone maintenance; Internal medicine","authors":[{"name":"Sauzanne Khalilieh","is_ca":false},{"name":"Ka Lai Yee","is_ca":false},{"name":"Rosa I. Sánchez","is_ca":false},{"name":"Kate Vaynshteyn","is_ca":false},{"name":"Fan Li","is_ca":false},{"name":"Shawn Searle","is_ca":false},{"name":"Mohammed Bouhajib","is_ca":true},{"name":"Marian Iwamoto","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08319404251493585,"gpt":0.4393486597931239,"spread":0.356154617278188,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004072781,0.000187819,0.00052415,0.0001624605,0.00004057712,0.000004467992,0.0001284657,0.000100654,0.0008959521],"category_scores_gemma":[0.00014463,0.0001308505,0.0000849133,0.0002885911,0.0001344617,0.00006588508,0.0001827058,0.0004300428,0.0001162408],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002731087,"about_ca_system_score_gemma":0.0005417687,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006813839,"about_ca_topic_score_gemma":0.00001240878,"domain_scores_codex":[0.9971682,0.0006419787,0.0009980581,0.0003843158,0.0005766529,0.0002307426],"domain_scores_gemma":[0.9986989,0.0005197428,0.0002551711,0.0001725849,0.0002381055,0.000115505],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002171607,0.000636803,0.8727962,0.00007939297,0.0006831055,0.000006890685,0.0009968053,0.00002947461,0.002331691,0.000004633795,0.004140302,0.1180775],"study_design_scores_gemma":[0.01162713,0.00005775101,0.9298526,0.0001534705,0.001007732,0.00001019697,0.0001149405,0.0009091439,0.03136013,0.00007599189,0.0246593,0.0001715998],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905162,0.000252264,0.000005754759,0.004699802,0.001345622,0.001516337,0.000001643975,0.00001824165,0.001644121],"genre_scores_gemma":[0.995533,0.0001240485,0.000989522,0.0005188368,0.0001262191,0.00009883747,0.00002168096,0.00001562034,0.00257225],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1179059,"threshold_uncertainty_score":0.9810047,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2981182356","doi":"10.1002/cpdd.747","title":"A Pharmacokinetic Bioequivalence Study Comparing Sublingual Riluzole (BHV‐0223) and Oral Tablet Formulation of Riluzole in Healthy Volunteers","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"Biohaven Pharmaceuticals","keywords":"Bioequivalence; Riluzole; Medicine; Pharmacokinetics; Geometric mean; Confidence interval; Adverse effect; Area under the curve; Sublingual administration; Pharmacology; Internal medicine; Amyotrophic lateral sclerosis; Mathematics","authors":[{"name":"Irfan Qureshi","is_ca":false},{"name":"Meghan Lovegren","is_ca":false},{"name":"Victoria Wirtz","is_ca":false},{"name":"Richard Larouche","is_ca":false},{"name":"Mario Tanguay","is_ca":true},{"name":"Matt S. Anderson","is_ca":false},{"name":"Sonja Hartmann","is_ca":false},{"name":"Vlad Coric","is_ca":false},{"name":"Robert Berman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08764181574720296,"gpt":0.4492870065205536,"spread":0.3616451907733506,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002982605,0.0002434782,0.0009459289,0.0004317022,0.00005019764,0.0000111807,0.0002505677,0.0001387064,0.0004119235],"category_scores_gemma":[0.0001739158,0.0002221277,0.00005951267,0.0005868991,0.0001935574,0.0001542694,0.000392525,0.0009094925,0.00006361003],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003459544,"about_ca_system_score_gemma":0.0004984706,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004835282,"about_ca_topic_score_gemma":0.0002444962,"domain_scores_codex":[0.9960225,0.0005269498,0.001669232,0.000642758,0.0004793045,0.0006592514],"domain_scores_gemma":[0.9985497,0.0006049217,0.0002176286,0.0001980817,0.0001454258,0.000284241],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003311627,0.002111814,0.9825736,0.0002207929,0.000109049,0.00006003121,0.002037875,0.0005503897,0.005333475,0.000004175373,0.0006379544,0.003049236],"study_design_scores_gemma":[0.01947414,0.0008179379,0.9613848,0.0001366568,0.00004616499,0.000005981798,0.0003000441,0.01550423,0.001085035,0.00001176798,0.001022088,0.0002111949],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954348,0.0002266224,0.00001061309,0.001180077,0.0007404062,0.002229511,0.000002042703,0.00003009541,0.0001458567],"genre_scores_gemma":[0.9978324,0.0001715641,0.000709033,0.0008229865,0.0001115576,0.00009116979,0.00001647613,0.00002508778,0.0002196989],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02118882,"threshold_uncertainty_score":0.9058106,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4391607838","doi":"10.1002/cpdd.1383","title":"Pharmacokinetics and Pharmacodynamics of Etripamil, an Intranasally Administered, Fast‐Acting, Nondihydropyridine Calcium Channel Blocker","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Altasciences (Canada); Vertex Pharmaceuticals (Canada); Cégep de Saint-Laurent","funders":"","keywords":"Medicine; Pharmacodynamics; Calcium channel blocker; Pharmacokinetics; Nasal administration; Pharmacology; Calcium channel; Anesthesia; Calcium; Internal medicine","authors":[{"name":"James E. Ip","is_ca":false},{"name":"Douglas Wight","is_ca":true},{"name":"Corinne Seng Yue","is_ca":false},{"name":"David H. Nguyen","is_ca":true},{"name":"Francis Plat","is_ca":true},{"name":"Bruce S. Stambler","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03845254996460452,"gpt":0.3985359675126638,"spread":0.3600834175480593,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001246206,0.0003816492,0.0009538569,0.000390348,0.00008041597,0.0000142267,0.0001778891,0.0002903482,0.0002429639],"category_scores_gemma":[0.00007750797,0.0003507943,0.0001874544,0.0004608964,0.000505649,0.0001133666,0.0001918146,0.001371136,0.00003663575],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001276731,"about_ca_system_score_gemma":0.0007006906,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009566716,"about_ca_topic_score_gemma":0.000009461972,"domain_scores_codex":[0.9966255,0.000336004,0.001389687,0.0008070783,0.0002404548,0.0006012463],"domain_scores_gemma":[0.9984516,0.0006382984,0.0001701532,0.0001985147,0.0001215452,0.0004199014],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0151117,0.008720546,0.02309955,0.004397117,0.007748026,0.02004394,0.01401211,0.001313279,0.5900853,0.0002699811,0.06317268,0.2520257],"study_design_scores_gemma":[0.04410377,0.004405258,0.09620896,0.00165013,0.004564281,0.002856207,0.0009909456,0.1879795,0.5165746,0.0004783422,0.136602,0.003586064],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908066,0.001941865,0.000216907,0.002116421,0.003607308,0.0006841806,0.00002055228,0.0001240051,0.0004821673],"genre_scores_gemma":[0.9921371,0.001922797,0.001354374,0.002715825,0.00103178,0.00006852296,0.0000797564,0.00005891074,0.000630972],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2484397,"threshold_uncertainty_score":0.9998944,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2937154946","doi":"10.1002/cpdd.685","title":"Evaluation of the Pharmacokinetics of Metformin Following Coadministration With Doravirine in Healthy Volunteers","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Pharma Medica Research (Canada)","funders":"","keywords":"Medicine; Pharmacokinetics; Pharmacology; Metformin; Pharmacokinetic interaction; Drug interaction; Internal medicine","authors":[{"name":"Rosa I. Sánchez","is_ca":false},{"name":"Ka Lai Yee","is_ca":false},{"name":"Fan Li","is_ca":false},{"name":"Dawn Cislak","is_ca":false},{"name":"Maureen Martell","is_ca":true},{"name":"Heather R. Jordan","is_ca":true},{"name":"Marian Iwamoto","is_ca":false},{"name":"Sauzanne Khalilieh","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05189335607255027,"gpt":0.4140086072678435,"spread":0.3621152511952932,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004717705,0.0001955391,0.0006377818,0.0002130227,0.00002614798,0.000002371933,0.0001647323,0.0001025974,0.0002295964],"category_scores_gemma":[0.0001297453,0.0001336484,0.0001078904,0.0005357871,0.0001219217,0.00006321867,0.00007780494,0.0003557059,0.00002136135],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004142656,"about_ca_system_score_gemma":0.00228983,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001841276,"about_ca_topic_score_gemma":0.0001958622,"domain_scores_codex":[0.9966494,0.0004601579,0.001439177,0.0003467039,0.0008269285,0.0002776234],"domain_scores_gemma":[0.9987847,0.0003341408,0.0003445099,0.0001943208,0.0002500863,0.00009223277],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001919556,0.002114454,0.9759403,0.0001610627,0.0005636507,0.00003084923,0.002091447,0.0005386182,0.002067006,0.00001474067,0.000898258,0.01366003],"study_design_scores_gemma":[0.04587925,0.0006240318,0.8637072,0.0005832394,0.001088144,0.00001617484,0.0007736208,0.004275115,0.0772495,0.00005166176,0.005406762,0.0003453362],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936246,0.000199859,0.000007638319,0.002200872,0.0008941489,0.002078187,0.000001792002,0.000009835223,0.000983079],"genre_scores_gemma":[0.9965234,0.00007607023,0.002057948,0.000405689,0.00003180045,0.0001255158,0.00002463508,0.0000161878,0.0007387958],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1122332,"threshold_uncertainty_score":0.5450022,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3215986232","doi":"10.1002/cpdd.1043","title":"The Effect of Oral Letermovir Administration on the Pharmacokinetics of a Single Oral Dose of P‐Glycoprotein Substrate Digoxin in Healthy Volunteers","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Digoxin; Medicine; Pharmacokinetics; Pharmacology; Tolerability; Oral administration; Crossover study; Internal medicine; Placebo; Adverse effect; Heart failure","authors":[{"name":"Jürgen Scheuenpflug","is_ca":false},{"name":"Dirk Kropeit","is_ca":false},{"name":"Katharina Erb‐Zohar","is_ca":false},{"name":"Jochen G.W. Theis","is_ca":false},{"name":"Hans‐Peter Stobernack","is_ca":false},{"name":"David McCormick","is_ca":false},{"name":"Holger Zimmermann","is_ca":false},{"name":"Helga Rübsamen‐Schaeff","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07222058166040611,"gpt":0.4252310117062345,"spread":0.3530104300458284,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00426071,0.0001904078,0.0007284178,0.0001353917,0.00005946347,0.000007654609,0.0002641828,0.0001384716,0.000250572],"category_scores_gemma":[0.0006159313,0.000118683,0.000144338,0.0005358715,0.0005862446,0.000030169,0.0001299012,0.0007999067,0.00001178522],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001604833,"about_ca_system_score_gemma":0.001159123,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008424197,"about_ca_topic_score_gemma":0.0006601622,"domain_scores_codex":[0.9959368,0.001259126,0.001645296,0.0003288602,0.0004347355,0.0003951615],"domain_scores_gemma":[0.9964972,0.002636707,0.0003158576,0.0002494578,0.0001726533,0.0001280838],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.08688839,0.008793138,0.3160012,0.001594212,0.001015525,0.0009295855,0.002516225,0.0002477082,0.406183,0.0001996406,0.008461143,0.1671703],"study_design_scores_gemma":[0.01047488,0.002884334,0.1268987,0.0002047475,0.00006546535,0.000008609853,0.000134678,0.0004389905,0.8507347,0.00002720613,0.007992896,0.0001348061],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.99309,0.0003113678,0.000002464815,0.004657657,0.0004069253,0.001153276,0.000008563386,0.000006993287,0.0003627855],"genre_scores_gemma":[0.998445,0.0003803249,0.0001754972,0.0006249458,0.00005082176,0.0001133063,0.00001349921,0.00001696232,0.0001795846],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4445517,"threshold_uncertainty_score":0.4839752,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3133802300","doi":"10.1002/cpdd.926","title":"Pharmacokinetic Interaction Among Ezetimibe, Rosuvastatin, and Telmisartan","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Medicine; Telmisartan; Rosuvastatin; Ezetimibe; Pharmacokinetic interaction; Pharmacology; Pharmacokinetics; Internal medicine; Drug interaction; Statin; Blood pressure","authors":[{"name":"Ki Young Huh","is_ca":false},{"name":"Sang Won Lee","is_ca":true},{"name":"Kyung Tae Kim","is_ca":true},{"name":"In‐Jin Jang","is_ca":false},{"name":"Seung‐Hwan Lee","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03683423971864972,"gpt":0.3937161031873667,"spread":0.356881863468717,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001414691,0.0001846708,0.0005744532,0.0001017685,0.00007687169,0.00001414465,0.00006653728,0.0001238504,0.0006704403],"category_scores_gemma":[0.0001759985,0.000172871,0.0001309715,0.0002367519,0.000165243,0.00007335652,0.0001425579,0.0007229206,0.00005559235],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000140173,"about_ca_system_score_gemma":0.0005465589,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002809861,"about_ca_topic_score_gemma":0.00005755574,"domain_scores_codex":[0.997525,0.0004029653,0.0009240429,0.0005386939,0.0002498868,0.0003593706],"domain_scores_gemma":[0.9989463,0.0002689917,0.0001176049,0.0001857964,0.0001402925,0.0003409886],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0006983206,0.00208442,0.412827,0.0005564319,0.001114162,0.003270905,0.002123904,0.00005113535,0.005129379,0.00001440256,0.03883946,0.5332904],"study_design_scores_gemma":[0.007990864,0.00008554256,0.8128983,0.0001650301,0.0002191116,0.000263204,0.0003173788,0.0005684847,0.02318748,0.00002756775,0.153994,0.000282949],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923032,0.001017551,0.00008735811,0.002501149,0.001813831,0.0005396442,0.000001309672,0.00004849621,0.001687456],"genre_scores_gemma":[0.9858953,0.0016114,0.004260575,0.00618108,0.0005705511,0.0001243363,0.00003305637,0.00002692903,0.001296798],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5330075,"threshold_uncertainty_score":0.7340851,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2992701293","doi":"10.1002/cpdd.753","title":"Pharmacokinetic Analysis of Weekly Versus Biweekly IgPro20 Dosing in Patients With Primary Immunodeficiency","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; Montreal Clinical Research Institute; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Dosing; Primary immunodeficiency; Pharmacokinetics; Intensive care medicine; Pharmacology; Internal medicine","authors":[{"name":"Mikhail Rojavin","is_ca":false},{"name":"Hugo Chapdelaine","is_ca":true},{"name":"Michael A. Tortorici","is_ca":false},{"name":"Michaela Praus","is_ca":false},{"name":"Gautam Baheti","is_ca":false},{"name":"Ying Zhang","is_ca":false},{"name":"Jutta Hofmann","is_ca":false},{"name":"Roxane Labrosse","is_ca":true},{"name":"Renée Dicaire","is_ca":true},{"name":"Élie Haddad","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01322076693013418,"gpt":0.2940168658577188,"spread":0.2807960989275846,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001427232,0.0003569582,0.001173479,0.0009686794,0.00009161482,0.000007654124,0.0006453821,0.0002737258,0.001198819],"category_scores_gemma":[0.00005566884,0.0003146992,0.0002024163,0.001831047,0.0004827668,0.0001475658,0.000255989,0.0008861835,0.0002583207],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002178181,"about_ca_system_score_gemma":0.0004050288,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008832079,"about_ca_topic_score_gemma":0.00001711294,"domain_scores_codex":[0.995986,0.0005861606,0.001818307,0.0007286012,0.0001396976,0.0007412424],"domain_scores_gemma":[0.9982152,0.0007983714,0.0004952425,0.0003452176,0.0001280545,0.00001789353],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007784498,0.005874081,0.933239,0.00008856109,0.002743952,0.00001111248,0.002600773,0.002813045,0.01682507,0.00002550325,0.0002583795,0.02773603],"study_design_scores_gemma":[0.02137783,0.0003145292,0.968411,0.00006089142,0.0004478244,4.263341e-7,0.0002660475,0.00006284389,0.003748564,0.000003434431,0.004891693,0.0004149557],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990496,0.0035506,0.00001071689,0.0001208468,0.003225264,0.0008035023,0.00001007149,0.00003720682,0.001745817],"genre_scores_gemma":[0.9985121,0.0001193311,0.0000972522,0.000416899,0.000003366883,0.00005279039,0.000265202,0.00002356871,0.0005095259],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03517196,"threshold_uncertainty_score":0.9999305,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2906348647","doi":"10.1002/cpdd.643","title":"Effect of Rifampicin on the Pharmacokinetics of a Single Dose of Vemurafenib in Patients With <i>BRAF</i> <sup>V600</sup> Mutation–Positive Metastatic Malignancy","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Vemurafenib; Medicine; Pharmacokinetics; Pharmacology; Area under the curve; Dosing; Rifampicin; Confidence interval; Internal medicine; Gastroenterology; Urology; Metastatic melanoma; Cancer; Pathology; Tuberculosis","authors":[{"name":"Weijiang Zhang","is_ca":false},{"name":"Christine McIntyre","is_ca":false},{"name":"Harper Forbes","is_ca":true},{"name":"Rabab Gaafar","is_ca":false},{"name":"Hanaa M Kohail","is_ca":false},{"name":"J. Thaddeus Beck","is_ca":false},{"name":"Stjepko Pleština","is_ca":false},{"name":"E. Bertrán","is_ca":false},{"name":"Todd Riehl","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01646367025858358,"gpt":0.3114050173212828,"spread":0.2949413470626992,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001106605,0.0002066295,0.0004730421,0.0001000602,0.00002810172,0.000002097197,0.000263735,0.00009612372,0.00004608703],"category_scores_gemma":[0.0001812774,0.0001404581,0.00007618639,0.0002184327,0.0004559628,0.000004756801,0.000118518,0.0001755562,0.000005766277],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002535948,"about_ca_system_score_gemma":0.0001679301,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008773456,"about_ca_topic_score_gemma":0.00001480077,"domain_scores_codex":[0.9974558,0.0007908298,0.0009701874,0.0003419706,0.0001968251,0.0002443475],"domain_scores_gemma":[0.9984826,0.0006641058,0.0004079856,0.0001923066,0.0001917209,0.00006127318],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.02633942,0.01297222,0.4845274,0.00080348,0.00185977,0.000107281,0.007681996,0.00176734,0.4248282,0.00009996117,0.005635659,0.03337723],"study_design_scores_gemma":[0.008269846,0.004814955,0.0717115,0.0001321202,0.00009129764,0.000001336886,0.00004542625,0.00005484518,0.9141328,0.00001239608,0.0005745203,0.0001589408],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983308,0.00006398036,0.0000260126,0.00008332675,0.0002234703,0.0008792715,0.00002740047,0.000003230186,0.0003625389],"genre_scores_gemma":[0.9987236,0.00002075556,0.0005456829,0.0004604669,0.00005994166,0.00006793179,0.00006233423,0.0000174689,0.00004178679],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4893046,"threshold_uncertainty_score":0.5727715,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2888696165","doi":"10.1002/cpdd.607","title":"Assessment of the Effects of Age and Renal Function on Pharmacokinetics of Bazedoxifene in Postmenopausal Women","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's Health Research Institute","funders":"Pfizer","keywords":"Medicine; Pharmacokinetics; Renal function; Selective estrogen receptor modulator; Placebo; Internal medicine; Osteoporosis; Impaired renal function; Postmenopausal women; Urology; Estrogen receptor; Cancer","authors":[{"name":"William McKeand","is_ca":false},{"name":"James Ermer","is_ca":true},{"name":"Joan Korth‐Bradley","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.008928351467708354,"gpt":0.3344801991064224,"spread":0.325551847638714,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008128311,0.0001305147,0.0003047459,0.00007522052,0.00002176236,0.000001208276,0.0001611928,0.0001693167,0.00001305834],"category_scores_gemma":[0.00008861945,0.00009701818,0.0000421465,0.0001459827,0.0004107303,0.000002237229,0.0001911211,0.0002526485,7.677079e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003454852,"about_ca_system_score_gemma":0.0001864059,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003575884,"about_ca_topic_score_gemma":0.000004977615,"domain_scores_codex":[0.9983715,0.0003861292,0.0006600695,0.0002569019,0.0001248555,0.0002005447],"domain_scores_gemma":[0.9992933,0.0002152859,0.0002413331,0.0001332968,0.00005648545,0.00006026432],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0006741909,0.0008120997,0.03455224,0.0001086915,0.0001973994,0.00001182136,0.0002222347,0.00003404923,0.9594908,0.00001872978,0.0006299083,0.003247881],"study_design_scores_gemma":[0.002967032,0.001452011,0.3651896,0.00006348678,0.00003170118,0.000001290649,0.0000153274,0.00003145214,0.6292741,0.00002384049,0.0008717107,0.00007843007],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980267,0.000234702,0.00001029172,0.00005665119,0.0009326153,0.0004023039,0.000001857874,0.000002283136,0.0003325843],"genre_scores_gemma":[0.998757,0.0003554386,0.0002976585,0.0003520232,0.0000918697,0.00003704947,0.000006540468,0.00001007504,0.00009233155],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3306373,"threshold_uncertainty_score":0.3956287,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4400593447","doi":"10.1002/cpdd.1436","title":"Food Effect and Pharmacokinetic Bridging of Avacopan in Caucasian and Japanese Healthy Participants","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Celerion (Canada)","funders":"","keywords":"Medicine; Pharmacokinetics; Crossover study; Placebo; Internal medicine; Tolerability; Area under the curve; Oral administration; Gastroenterology; Randomized controlled trial; Pharmacology; Adverse effect; Pathology","authors":[{"name":"Shichang Miao","is_ca":false},{"name":"Pirow Bekker","is_ca":false},{"name":"Danielle Armas","is_ca":false},{"name":"Mary Lor","is_ca":true},{"name":"Ryuzo Hanada","is_ca":false},{"name":"Shota Okamura","is_ca":false},{"name":"Yuko Umezawa","is_ca":false},{"name":"Ashit Trivedi","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03734745860357723,"gpt":0.4049165509674602,"spread":0.367569092363883,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001312905,0.0001596078,0.0005384576,0.0002617478,0.00003725911,0.000007807288,0.000051374,0.0001270045,0.00011226],"category_scores_gemma":[0.00008847906,0.0001329459,0.00005264632,0.0002680832,0.0002201295,0.00004388131,0.00008327603,0.0006511398,0.00001468706],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007550459,"about_ca_system_score_gemma":0.000254125,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002217518,"about_ca_topic_score_gemma":0.0000528864,"domain_scores_codex":[0.9979258,0.0002936264,0.0008920897,0.0004012269,0.0001142399,0.0003729999],"domain_scores_gemma":[0.9989367,0.0006412535,0.00005776403,0.00007457031,0.00002116285,0.0002685443],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002199569,0.00236328,0.7272623,0.005177748,0.002039493,0.004533594,0.03030214,0.00007189294,0.007134692,0.00008694963,0.009766982,0.2090614],"study_design_scores_gemma":[0.01450064,0.001231303,0.9700847,0.001257552,0.0004618584,0.0003027454,0.0002658416,0.003619723,0.003601911,0.00008514622,0.004263827,0.0003248112],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886822,0.004940617,0.000002129566,0.004552502,0.0009580699,0.0006449785,0.000003912513,0.00003454744,0.0001811104],"genre_scores_gemma":[0.9969308,0.001702151,0.0001244423,0.0008991667,0.0001141924,0.0001052683,0.00001023657,0.00001740319,0.00009633139],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2428223,"threshold_uncertainty_score":0.5421376,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3008901859","doi":"10.1002/cpdd.773","title":"Absolute Bioavailability of Vemurafenib in Patients With <i>BRAF</i><sup>V600</sup> Mutation–Positive Malignancies","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Roche (Canada)","funders":"","keywords":"Vemurafenib; Medicine; Bioavailability; Mutation; Internal medicine; Cancer research; Oncology; Pharmacology; Cancer; Genetics; Metastatic melanoma; Gene","authors":[{"name":"Weijiang Zhang","is_ca":false},{"name":"Dawn Colburn","is_ca":false},{"name":"Brian Simmons","is_ca":false},{"name":"Zsuzsanna Pápai","is_ca":false},{"name":"Enric Bertran","is_ca":false},{"name":"Simone Schadt","is_ca":false},{"name":"Christophe Husser","is_ca":false},{"name":"Harper Forbes","is_ca":true},{"name":"Dieter Roethlisberger","is_ca":false},{"name":"Thomas Härtung","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01810976022212002,"gpt":0.2810174184975781,"spread":0.262907658275458,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004987153,0.0002031479,0.0003896515,0.00005313594,0.00003496135,0.00000475635,0.0002480272,0.0001725744,0.00006266226],"category_scores_gemma":[0.0001405646,0.0001816068,0.00006446832,0.0001961853,0.0002665583,0.000008324729,0.0001961071,0.0002350348,0.00002591686],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003819976,"about_ca_system_score_gemma":0.0003589571,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001019295,"about_ca_topic_score_gemma":0.00003424761,"domain_scores_codex":[0.9977996,0.0002759442,0.0009003503,0.0005605985,0.000154235,0.0003092491],"domain_scores_gemma":[0.9992395,0.0001186769,0.0001990395,0.0001468859,0.0001432259,0.0001526446],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002677216,0.001819499,0.968222,0.0001268144,0.0002440726,0.00008104715,0.003348937,0.0007422973,0.01163732,0.0000161533,0.006149479,0.004935181],"study_design_scores_gemma":[0.0069459,0.0007312906,0.8901299,0.00003738681,0.00002769224,0.000001331065,0.0001373711,0.0000842524,0.08985344,0.00001344221,0.01170167,0.0003363613],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980971,0.00009401143,0.00003940207,0.0005349955,0.0001972962,0.0007175207,0.00003016991,0.00001053147,0.000278951],"genre_scores_gemma":[0.9959898,0.00003209421,0.001361427,0.002157465,0.00009973479,0.0000919201,0.0001855617,0.00001672057,0.00006525374],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07821611,"threshold_uncertainty_score":0.7405709,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4390599050","doi":"10.1002/cpdd.1364","title":"Effect of Tacrolimus Formulation (Prolonged‐Release vs Immediate‐Release) on Its Susceptibility to Drug‐Drug Interactions with St. John's Wort","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"CYP3A; CYP3A4; Tacrolimus; Pharmacology; Medicine; Pharmacokinetics; Drug interaction; CYP3A5; Calcineurin; Crossover study; P-glycoprotein; Pharmacokinetic interaction; Cmax; Inducer; Cytochrome P450; Internal medicine; Metabolism; Chemistry; Transplantation; Antibiotics; Biochemistry","authors":[{"name":"Katja S. Gümüs","is_ca":false},{"name":"Anna Teegelbekkers","is_ca":false},{"name":"Max Sauter","is_ca":false},{"name":"Andreas D. Meid","is_ca":false},{"name":"Jürgen Burhenne","is_ca":false},{"name":"Johanna Weiß","is_ca":false},{"name":"Antje Blank","is_ca":false},{"name":"Walter E. Haefeli","is_ca":false},{"name":"David Czock","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07446660461163242,"gpt":0.4725914293935504,"spread":0.398124824781918,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.006765561,0.0007785872,0.001255195,0.0007529354,0.0002827941,0.00003967042,0.000722896,0.0003274515,0.002302469],"category_scores_gemma":[0.0003871548,0.0006514548,0.0003336374,0.001060237,0.0003272014,0.0002475773,0.0003756463,0.002970068,0.0008972191],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004249095,"about_ca_system_score_gemma":0.0008036863,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000306149,"about_ca_topic_score_gemma":0.000239368,"domain_scores_codex":[0.9917203,0.002978043,0.002193957,0.001425059,0.0005234503,0.001159177],"domain_scores_gemma":[0.9922435,0.005710079,0.0003813831,0.0003933464,0.0002810053,0.0009906705],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.06409511,0.01084703,0.1339435,0.002711745,0.004580063,0.002281061,0.01446718,0.03409695,0.0519399,0.0003650859,0.2544496,0.4262227],"study_design_scores_gemma":[0.01234826,0.00101259,0.03779965,0.0003212123,0.001147638,0.00003314803,0.0001119586,0.01123,0.4286254,0.00009721654,0.5059714,0.001301533],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9796193,0.001149504,0.0000473996,0.00382001,0.01108112,0.002782438,0.0001532102,0.0002161726,0.001130885],"genre_scores_gemma":[0.990294,0.0007139752,0.0002688789,0.005030493,0.001072082,0.0008136334,0.0001264578,0.00009702073,0.001583428],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4249212,"threshold_uncertainty_score":0.9998807,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4409504657","doi":"10.1002/cpdd.1534","title":"A Phase 1C, Open Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of DM199 Administered Intravenously with a Polyvinyl Chloride Bag in Adult Healthy Subjects and Adults Recently Taking Angiotensin‐Converting Enzyme Inhibitors","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"","keywords":"Tolerability; Medicine; Pharmacokinetics; Adverse effect; Dosing; Context (archaeology); Anesthesia; Pharmacology; Internal medicine","authors":[{"name":"Michael Giuffre","is_ca":true},{"name":"Annette Lista","is_ca":false},{"name":"Nick B. Paulson","is_ca":false},{"name":"Lorianne K. Masuoka","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06909627066100327,"gpt":0.4269343132692811,"spread":0.3578380426082778,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003735752,0.0003787894,0.001137897,0.0003547693,0.0002046953,0.00004489377,0.0003078496,0.0001183506,0.0000307479],"category_scores_gemma":[0.0008486823,0.0002990244,0.0000449313,0.0008500064,0.0002986923,0.0001199774,0.0007077724,0.0005732475,0.000001783146],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003017512,"about_ca_system_score_gemma":0.0009414412,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005310326,"about_ca_topic_score_gemma":0.002398991,"domain_scores_codex":[0.9952303,0.0006787506,0.002238283,0.0009095737,0.0003394333,0.000603701],"domain_scores_gemma":[0.9972284,0.001430498,0.0004529266,0.0002732003,0.0002887911,0.000326215],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05623127,0.02003417,0.6538818,0.0005851344,0.0006946517,0.0003473383,0.04211775,0.0000415736,0.004435994,0.00002210529,0.0008107312,0.2207975],"study_design_scores_gemma":[0.1491501,0.00940665,0.765847,0.003753628,0.0007676435,0.00007561907,0.007405452,0.003642295,0.05737421,0.00005957919,0.001607502,0.0009102746],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9836317,0.0005939951,0.0000121037,0.01043096,0.0008678075,0.00435715,0.000006184138,0.00003143335,0.00006867851],"genre_scores_gemma":[0.9921522,0.000233035,0.001095558,0.006144169,0.0001421945,0.0001320977,0.00001513457,0.00003181994,0.00005383704],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2198872,"threshold_uncertainty_score":0.9999462,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4409956934","doi":"10.1002/cpdd.1538","title":"A Randomized Phase 1 Study Evaluating Pharmacokinetics, Safety, and Tolerability of a High‐Concentration, Long‐Acting Cabotegravir Formulation in Adults Without HIV","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"GlaxoSmithKline (Canada)","funders":"ViiV Healthcare","keywords":"Medicine; Tolerability; Dosing; Pharmacokinetics; Adverse effect; Pharmacology; Regimen; Internal medicine","authors":[{"name":"Kelong Han","is_ca":false},{"name":"Paul Benn","is_ca":false},{"name":"Jörg Sievers","is_ca":false},{"name":"David Dorey","is_ca":true},{"name":"Michael Warwick‐Sanders","is_ca":false},{"name":"Randa Hareedy","is_ca":false},{"name":"Louise M. Harkness","is_ca":false},{"name":"Claudia Leemereise","is_ca":false},{"name":"Kjersten Offenbecker","is_ca":false},{"name":"Christina Donatti","is_ca":false},{"name":"Darin Brimhall","is_ca":false},{"name":"Christian Schwabe","is_ca":false},{"name":"Craig Boyle","is_ca":false},{"name":"Michael Hassman","is_ca":false},{"name":"Ronald D’Amico","is_ca":false},{"name":"William Spreen","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0388030569631078,"gpt":0.4428926940845356,"spread":0.4040896371214278,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006485094,0.0003434613,0.001721334,0.0003239215,0.0001022831,0.00001173547,0.0001288488,0.0001427785,0.0001161451],"category_scores_gemma":[0.001039841,0.0002935447,0.0001087112,0.0005218897,0.0002218333,0.0001128086,0.0001543478,0.0005409658,0.000006044614],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004190234,"about_ca_system_score_gemma":0.0009219371,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007481312,"about_ca_topic_score_gemma":0.0002053256,"domain_scores_codex":[0.9939614,0.001275697,0.003271402,0.0007354619,0.0003495963,0.0004064727],"domain_scores_gemma":[0.9968377,0.002034521,0.0005054463,0.000188748,0.0002776214,0.0001559857],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1335639,0.006960354,0.7943307,0.0002700796,0.0007218755,0.00007381995,0.009340967,0.0001842854,0.0001366565,0.00001947006,0.0002199586,0.05417787],"study_design_scores_gemma":[0.6877207,0.0002249863,0.2917096,0.000687558,0.0006255563,0.00000354372,0.0008689224,0.01479465,0.002733852,0.0001296275,0.0002002358,0.0003008282],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990444,0.000296982,0.0003398454,0.002475525,0.0006102137,0.005532117,0.00000384643,0.00003973336,0.0002577424],"genre_scores_gemma":[0.9938616,0.0002675438,0.004206635,0.0003719013,0.00006357885,0.0004061073,0.00008682676,0.00001704697,0.0007187451],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5541567,"threshold_uncertainty_score":0.9999517,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2531615040","doi":"10.1002/cpdd.319","title":"Comparison of the Pharmacokinetics of Ketorolac Tromethamine After Continuous Subcutaneous Infusion and Repeat Intramuscular Bolus Injections in Healthy Adult Subjects","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Pharmacological Receptor Mechanisms and Effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Celerion (Canada)","funders":"","keywords":"Medicine; Ketorolac Tromethamine; Pharmacokinetics; Anesthesia; Bolus (digestion); Cmax; Crossover study; Intramuscular injection; Ketorolac; Bioavailability; Regimen; Analgesic; Pharmacology; Surgery; Placebo","authors":[{"name":"Michael D. Burdick","is_ca":false},{"name":"Richard D. Mamelok","is_ca":false},{"name":"Michele Hurliman","is_ca":false},{"name":"Mariève Dupuis","is_ca":true},{"name":"Yuli Xie","is_ca":false},{"name":"Julie Grenier","is_ca":true},{"name":"Curtis Sheldon","is_ca":false},{"name":"Michael Gartner","is_ca":false},{"name":"Peter D. Noymer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01752693990052712,"gpt":0.3565817520965321,"spread":0.339054812196005,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009881825,0.0002194449,0.000576726,0.0001032379,0.00004171403,0.000003088445,0.000264827,0.0002630165,0.00008373638],"category_scores_gemma":[0.0004323434,0.0001426181,0.0001100902,0.0002240834,0.0003338603,0.000006150604,0.0003832434,0.0003269916,0.000002369338],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006479096,"about_ca_system_score_gemma":0.0001850142,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001987061,"about_ca_topic_score_gemma":0.0001238299,"domain_scores_codex":[0.9971108,0.0006798906,0.001187223,0.0004744551,0.0001766668,0.0003709921],"domain_scores_gemma":[0.998791,0.000415457,0.0003316478,0.0001858826,0.0001322575,0.0001437878],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003550606,0.001087617,0.1972783,0.00008375011,0.00009135806,0.00002279073,0.0002730186,0.00002963077,0.7742177,0.000005735475,0.001188585,0.02217094],"study_design_scores_gemma":[0.006504141,0.00123397,0.238845,0.0001100864,0.00005749664,0.00001600534,0.00006324014,0.00008942177,0.7466451,0.00004439849,0.006121354,0.0002697793],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965303,0.0007557275,0.00007735488,0.0006131685,0.001313347,0.0006524906,0.00001023519,0.00000798729,0.00003939869],"genre_scores_gemma":[0.9966062,0.001496998,0.0005228689,0.001066026,0.0001096947,0.0001084808,0.000005798316,0.00001670348,0.00006727012],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0415667,"threshold_uncertainty_score":0.5815796,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2761677898","doi":"10.1002/cpdd.394","title":"Categorization of Abuse Potential–Related Adverse Events","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Categorization; Adverse effect; Medical emergency; Pharmacology; Artificial intelligence","authors":[{"name":"Edward M. Sellers","is_ca":true},{"name":"Myroslava K. Romach","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1322844439839624,"gpt":0.5026786822963262,"spread":0.3703942383123637,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002495289,0.0003623107,0.0006997739,0.0002710603,0.0006531266,0.000007955815,0.001032401,0.0005210704,0.001895161],"category_scores_gemma":[0.0002125286,0.0003729588,0.0002452788,0.0002060202,0.0006536887,0.0004415896,0.00027832,0.001578136,0.0006169853],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001848091,"about_ca_system_score_gemma":0.0004946746,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003549534,"about_ca_topic_score_gemma":0.00003314542,"domain_scores_codex":[0.9957811,0.0007530173,0.001878279,0.0006487136,0.0002533195,0.0006855252],"domain_scores_gemma":[0.9973761,0.0004746823,0.001145639,0.0004295754,0.0001919386,0.0003820442],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002229168,0.008074247,0.8362294,0.0002628235,0.002337482,0.0009511495,0.005662203,0.01452158,0.06762917,0.000492421,0.03482503,0.02678528],"study_design_scores_gemma":[0.02151576,0.00009407593,0.6024475,0.0001027091,0.0006344206,0.00004095445,0.0003839426,0.005585694,0.112454,0.0008772533,0.2547595,0.001104274],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9814181,0.0001164821,0.00006354698,0.001152536,0.01192763,0.0007625557,0.00002612903,0.00008957661,0.004443453],"genre_scores_gemma":[0.9932367,0.001579691,0.0003251683,0.001506481,0.0003492225,0.000123422,0.00006877996,0.00003677189,0.002773715],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.233782,"threshold_uncertainty_score":0.9998722,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2953947897","doi":"10.1002/cpdd.720","title":"A First‐in‐Human Phase 1 Randomized Single and Multiple Ascending Dose Study of RPh201 in Healthy Volunteers","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Medicinal Plants and Neuroprotection","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Tolerability; Adverse effect; Dosing; Placebo; Randomized controlled trial; Erythema; Single Center; Anesthesia; Internal medicine; Surgery; Pathology","authors":[{"name":"Zadik Hazan","is_ca":false},{"name":"Konstantin Adamsky","is_ca":false},{"name":"Andre Lucassen","is_ca":false},{"name":"Leonard A. Levin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06716203326062947,"gpt":0.4218195771529872,"spread":0.3546575438923578,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00345151,0.0001659969,0.001141141,0.0003999859,0.00003478361,0.000002986349,0.00008054119,0.0001053387,0.0001682415],"category_scores_gemma":[0.0005093893,0.0001371813,0.00004795109,0.0002255395,0.0001296671,0.00004594681,0.00007554401,0.0006483245,0.00001145077],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001504804,"about_ca_system_score_gemma":0.0001203268,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003253651,"about_ca_topic_score_gemma":0.0007340292,"domain_scores_codex":[0.9969379,0.000576937,0.001538906,0.0004476122,0.0001963878,0.0003022301],"domain_scores_gemma":[0.9980285,0.001460703,0.0002122824,0.0001152512,0.00003191776,0.0001513665],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2629333,0.02257578,0.6821166,0.0005754012,0.0002012493,0.0007057492,0.01215577,0.0001305042,0.01281516,0.000003440028,0.0005957556,0.005191273],"study_design_scores_gemma":[0.7741159,0.002767749,0.2154656,0.0004135364,0.00007505357,0.00002103318,0.001209179,0.003462347,0.001353562,0.00001102661,0.000903774,0.0002012544],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946873,0.0001053506,0.000004291683,0.0006463056,0.0009573487,0.003451534,7.112332e-7,0.00001498901,0.0001322366],"genre_scores_gemma":[0.9986874,0.0001199336,0.0001396674,0.0007583561,0.00006566109,0.00009371641,0.000005255144,0.00001396755,0.0001160507],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5111826,"threshold_uncertainty_score":0.5594091,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3017244061","doi":"10.1002/cpdd.788","title":"Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine (a CYP1A2 Substrate) in Patients With <i>BRAF</i><sup>V600</sup> Mutation–Positive Malignancies","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Pharmacokinetics; Vemurafenib; Pharmacology; Mutation; Oncology; Internal medicine; Cancer research; Genetics; Cancer; Gene","authors":[{"name":"Weijiang Zhang","is_ca":false},{"name":"Christine McIntyre","is_ca":false},{"name":"Todd Riehl","is_ca":false},{"name":"Harper Forbes","is_ca":true},{"name":"Enric Bertran","is_ca":false},{"name":"Hye Jin Choi","is_ca":false},{"name":"Dae Ho Lee","is_ca":false},{"name":"Jeeyun Lee","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01806922812262594,"gpt":0.2851740033891128,"spread":0.2671047752664868,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006724622,0.0002078367,0.0004619129,0.00005716635,0.00002229694,0.00000248577,0.0002639523,0.0001233885,0.00003564781],"category_scores_gemma":[0.0001857295,0.0001459862,0.00007689869,0.0002237605,0.0002731512,0.000004918107,0.0001191057,0.0002059827,0.000003883611],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001982168,"about_ca_system_score_gemma":0.0001680401,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005196146,"about_ca_topic_score_gemma":0.000006001005,"domain_scores_codex":[0.9978158,0.0005134566,0.0009122474,0.0003434926,0.0001909699,0.0002240457],"domain_scores_gemma":[0.9988157,0.000472081,0.0003532924,0.0001311786,0.0001448885,0.0000828648],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0141867,0.003701942,0.3469602,0.0004881778,0.0006052979,0.0000766475,0.003946029,0.004264952,0.6177489,0.00004424074,0.002848211,0.00512881],"study_design_scores_gemma":[0.006470987,0.003075024,0.08383639,0.00007340326,0.00005145332,7.804169e-7,0.00006454289,0.00007540613,0.9057941,0.000003845179,0.0004057312,0.000148324],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984789,0.00008480599,0.00001485896,0.0002824851,0.0001312759,0.0007617009,0.00003173586,0.000004480346,0.0002097044],"genre_scores_gemma":[0.9988315,0.00003837059,0.0001847974,0.0007115816,0.00005814229,0.00005031235,0.00009252293,0.00001721476,0.00001562987],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2880453,"threshold_uncertainty_score":0.5953144,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2793645751","doi":"10.1002/cpdd.433","title":"Pharmacokinetic Drug Interaction Study of Bazedoxifene and Ibuprofen","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's Health Research Institute","funders":"Pfizer","keywords":"Pharmacokinetics; Ibuprofen; Medicine; Bioequivalence; Crossover study; Pharmacology; Confidence interval; Internal medicine; Urology; Placebo; Pathology","authors":[{"name":"William McKeand","is_ca":false},{"name":"Susan Baird‐Bellaire","is_ca":false},{"name":"James Ermer","is_ca":true},{"name":"Alain Patat","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02197730178811429,"gpt":0.3875958379826537,"spread":0.3656185361945394,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008494408,0.0001673943,0.0002763566,0.00008439057,0.00006335958,0.000004952898,0.0001825439,0.0001307575,0.00005664347],"category_scores_gemma":[0.00005296586,0.0001500277,0.0000419078,0.0001166306,0.0002357794,0.000005272437,0.0002797808,0.0003049677,0.00002481169],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000191244,"about_ca_system_score_gemma":0.0001018886,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001354236,"about_ca_topic_score_gemma":0.00003631433,"domain_scores_codex":[0.998116,0.0004021141,0.0007058476,0.0004392094,0.0001026817,0.0002341198],"domain_scores_gemma":[0.9993868,0.00009835805,0.0001720366,0.0001458975,0.00008400639,0.0001128642],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0450992,0.01757742,0.2316885,0.0001636918,0.002243622,0.0001433177,0.008866834,0.00008328746,0.5536443,0.000008084528,0.08026423,0.06021749],"study_design_scores_gemma":[0.07897799,0.004228085,0.09742223,0.00006121639,0.0002121162,0.00002498171,0.001271431,0.0002484217,0.7823686,0.00002117346,0.03452017,0.0006435786],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996498,0.0003302987,0.00000609292,0.0001474449,0.001747672,0.0007934931,7.564314e-7,0.000011443,0.0004647234],"genre_scores_gemma":[0.9980207,0.0002892397,0.000257158,0.0004351352,0.0003717133,0.00008913416,0.00001304909,0.00001661721,0.0005072155],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2287243,"threshold_uncertainty_score":0.6117953,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2141030907","doi":"10.1002/cpdd.48","title":"Differential Pharmacokinetics of Ganitumab in Patients With Metastatic Pancreatic Cancer Versus Other Advanced Solid Cancers","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Quebec Rehabilitation Research Network","funders":"","keywords":"Gemcitabine; Medicine; Pancreatic cancer; Pharmacokinetics; Oncology; Internal medicine; Volume of distribution; Response Evaluation Criteria in Solid Tumors; Cancer; Clinical trial; Pharmacology; Phases of clinical research","authors":[{"name":"Min Zhu","is_ca":false},{"name":"Nathalie Gosselin","is_ca":true},{"name":"Mita Kuchimanchi","is_ca":false},{"name":"Jessica Johnson","is_ca":false},{"name":"Ian McCaffery","is_ca":false},{"name":"Samer Mouksassi","is_ca":true},{"name":"Elwyn Loh","is_ca":false},{"name":"Jianfeng Lü","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05145983826760502,"gpt":0.429606022472052,"spread":0.378146184204447,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004092455,0.0002778369,0.001218416,0.0002562026,0.00003968475,0.000005033979,0.000216731,0.0001132965,0.004448595],"category_scores_gemma":[0.0001422718,0.0002121531,0.00006833385,0.0003525264,0.0004471932,0.00007955136,0.0001366227,0.0006373356,0.00006251795],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006400103,"about_ca_system_score_gemma":0.001455018,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004660319,"about_ca_topic_score_gemma":0.0003800233,"domain_scores_codex":[0.9968768,0.0003366036,0.001298044,0.0004605534,0.0004057629,0.0006222615],"domain_scores_gemma":[0.998091,0.0009006824,0.0002889946,0.0001861138,0.0002637803,0.0002694183],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006846498,0.00207527,0.9737059,0.0001917174,0.000885298,0.00003202198,0.0007310932,0.000122703,0.0006042285,0.000002893034,0.002133873,0.01266843],"study_design_scores_gemma":[0.04969651,0.0006533604,0.9444703,0.0002228868,0.0004357848,7.278649e-7,0.0001501099,0.000836287,0.002618029,0.00001830545,0.0006529585,0.0002447673],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958394,0.0001535606,0.00002421595,0.0004645654,0.000861685,0.00196996,0.000009290446,0.00001904542,0.0006582982],"genre_scores_gemma":[0.9948373,0.0003862493,0.002612885,0.0007369702,0.00008770507,0.0008181164,0.00002321764,0.00003594697,0.0004615939],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04285001,"threshold_uncertainty_score":0.9964615,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2800574556","doi":"10.1002/cpdd.458","title":"A Study of the Potential Interaction Between Bazedoxifene and Atorvastatin in Healthy Postmenopausal Women","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's Health Research Institute","funders":"Pfizer","keywords":"Atorvastatin; Cmax; Medicine; Pharmacokinetics; Pharmacology; Dosing; Urology; Internal medicine","authors":[{"name":"William McKeand","is_ca":false},{"name":"Susan Baird‐Bellaire","is_ca":true},{"name":"James Ermer","is_ca":false},{"name":"Alain Patat","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04281427300583475,"gpt":0.4065403169503107,"spread":0.363726043944476,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003052734,0.0001308484,0.0005862371,0.0001281924,0.00006817079,0.000003737519,0.0001127227,0.0000919402,0.00006464106],"category_scores_gemma":[0.0001012382,0.00009509754,0.00004471464,0.0002648346,0.0001754615,0.00003935882,0.0002043117,0.0005233591,0.0000091383],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002729051,"about_ca_system_score_gemma":0.0005321871,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000170257,"about_ca_topic_score_gemma":0.0002449214,"domain_scores_codex":[0.9972154,0.0007508051,0.001084639,0.0003556116,0.0002688952,0.0003246858],"domain_scores_gemma":[0.9991912,0.0001773828,0.0001877563,0.0001935285,0.00008146232,0.0001686955],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003081722,0.003425097,0.9099318,0.0001350591,0.0005110009,0.0001051082,0.01409212,0.000005129938,0.0004183812,0.000002375069,0.0006439187,0.06764833],"study_design_scores_gemma":[0.009666651,0.001747203,0.9837924,0.00004913794,0.00005411602,0.00001541878,0.002184062,0.00001584792,0.000550419,0.00001949798,0.001817792,0.00008742257],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960034,0.00007074066,0.000006342226,0.001313745,0.001113309,0.001417448,0.000001318135,0.00001102528,0.00006267653],"genre_scores_gemma":[0.997411,0.00005855682,0.0002735297,0.001591291,0.0004814247,0.0001321389,0.000002507037,0.00001278997,0.00003678948],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07386068,"threshold_uncertainty_score":0.3877965,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4318332812","doi":"10.1002/cpdd.1210","title":"A Randomized, Double‐Blind, Parallel Design Thorough QT Study With a Nested Crossover to Compare the Cardiac Safety of Amiselimod With Placebo and Positive Control in Healthy Volunteers","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Salix Pharmaceuticals; Bausch Health; Mitsubishi Tanabe Pharma Corporation","keywords":"Medicine; Placebo; Moxifloxacin; Crossover study; Dosing; QT interval; Anesthesia; Pharmacokinetics; Adverse effect; Confidence interval; Oral administration; Internal medicine; Antibiotics","authors":[{"name":"Jimin Lee","is_ca":false},{"name":"Robert Lester","is_ca":false},{"name":"Terry O’Reilly","is_ca":false},{"name":"Ezra R. Lowe","is_ca":false},{"name":"Neal E. Slatkin","is_ca":false},{"name":"Howard Franklin","is_ca":false},{"name":"Robert J. Israel","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03947145882336801,"gpt":0.366629509452682,"spread":0.327158050629314,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004756499,0.0002631486,0.0009861536,0.0001132656,0.0001116312,0.00001605266,0.0002469428,0.00009061387,0.000005364388],"category_scores_gemma":[0.0001116692,0.0001683794,0.00007089291,0.0003849952,0.0003372442,0.000007519451,0.0001511445,0.0003168467,0.000004033887],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003539544,"about_ca_system_score_gemma":0.0004754564,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001798926,"about_ca_topic_score_gemma":0.0004438556,"domain_scores_codex":[0.9963217,0.001513169,0.0009441469,0.0005837093,0.0002089659,0.000428348],"domain_scores_gemma":[0.9982727,0.001051343,0.0001906263,0.000192082,0.0001407163,0.0001525067],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9281939,0.0004806525,0.04302495,0.00001945992,0.0007688079,0.00004281199,0.005087138,0.02058016,0.000751146,0.000006710925,0.0007862484,0.0002580269],"study_design_scores_gemma":[0.8808228,0.0008930757,0.109819,0.00008146443,0.000294797,0.000007815026,0.002766369,0.0009103025,0.002436608,0.000006428848,0.001472255,0.0004890091],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912924,0.0003506665,0.002132064,0.0008326393,0.0002843371,0.005052113,0.0000119657,0.00001376864,0.00003010685],"genre_scores_gemma":[0.9958697,0.000224077,0.0009974691,0.001752965,0.0001110546,0.000924186,0.00003271059,0.00002447978,0.00006334647],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06679408,"threshold_uncertainty_score":0.6866313,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2123762312","doi":"10.1002/cpdd.35","title":"Pharmacokinetics of Irinotecan With and Without Panitumumab Coadministration in Patients With Metastatic Colorectal Cancer","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"Pfizer; Amgen","keywords":"Medicine; Panitumumab; Irinotecan; Pharmacokinetics; Colorectal cancer; Oncology; Pharmacology; Internal medicine; Cancer; Cetuximab","authors":[{"name":"Bingbing Yang","is_ca":false},{"name":"Chi‐Yuan Wu","is_ca":false},{"name":"Eric X. Chen","is_ca":true},{"name":"Jeffrey R. Infante","is_ca":false},{"name":"Alin Chen","is_ca":false},{"name":"Bing Gao","is_ca":false},{"name":"Brian P. Smith","is_ca":false},{"name":"Jason B. Litten","is_ca":false},{"name":"Hagen F. Kennecke","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0298835490165456,"gpt":0.3673054002709479,"spread":0.3374218512544023,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001984541,0.0002042977,0.0006004287,0.0001135857,0.00003668185,0.000005974392,0.00005576232,0.00004455587,0.0001729591],"category_scores_gemma":[0.00002072099,0.000136427,0.00002146322,0.0002019867,0.0003193589,0.00006390152,0.0000530304,0.0002578059,0.000003477848],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000177265,"about_ca_system_score_gemma":0.0004244642,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001849597,"about_ca_topic_score_gemma":0.001017808,"domain_scores_codex":[0.9984494,0.0000960966,0.0006561594,0.0003329616,0.000207392,0.000257965],"domain_scores_gemma":[0.9992945,0.0001571211,0.0001861828,0.00006018329,0.0001777419,0.0001242416],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00314605,0.001703792,0.9780089,0.00008089717,0.0003974365,0.00001887346,0.0008641567,0.00001404835,0.00009892386,0.00000165661,0.0002947227,0.01537053],"study_design_scores_gemma":[0.01705534,0.001576263,0.9778934,0.0001233749,0.0002026814,0.00000300576,0.0001474904,0.00007467548,0.002431838,0.00000646849,0.0003278021,0.0001576303],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973356,0.0001855034,0.000004763575,0.0005761643,0.0001670561,0.001491584,0.000006066363,0.00001287654,0.0002203758],"genre_scores_gemma":[0.9968954,0.0002289119,0.001781364,0.0004204132,0.00002609523,0.00053497,0.00001672953,0.00001613813,0.0000800249],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0152129,"threshold_uncertainty_score":0.5563331,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4384126864","doi":"10.1002/cpdd.1300","title":"Comparative Bioavailability of Two Daily Subcutaneous Doses Versus a Single Dose of Intramuscular and Vaginal Progesterone Formulations in Healthy Postmenopausal Females","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Ovarian function and disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Bioavailability; Luteal phase; Crossover study; Pharmacokinetics; Estrous cycle; Internal medicine; Hormone; Pharmacology","authors":[{"name":"Mario Tanguay","is_ca":true},{"name":"Barbara Cometti","is_ca":false},{"name":"Sylvie Boudreault","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1382611868117648,"gpt":0.443334695507818,"spread":0.3050735086960531,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009132476,0.0001426255,0.0006038935,0.0002660307,0.00003515081,0.000003129154,0.00006942246,0.00009004477,0.00009669445],"category_scores_gemma":[0.0001696865,0.0001328708,0.00003862824,0.0005126642,0.000434653,0.0000497607,0.00008926984,0.0002747836,0.00001732551],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001125355,"about_ca_system_score_gemma":0.0004962292,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004343729,"about_ca_topic_score_gemma":0.0003409808,"domain_scores_codex":[0.9979067,0.0002573025,0.001086018,0.0003341079,0.0001581998,0.0002576228],"domain_scores_gemma":[0.9984905,0.0009633877,0.0001870275,0.0001187684,0.0001026773,0.0001377064],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04319278,0.009903808,0.9070687,0.0007637176,0.0006206834,0.0003088861,0.0125938,0.0003548695,0.01055911,0.0002491052,0.001624403,0.01276013],"study_design_scores_gemma":[0.02650152,0.00287814,0.9649689,0.00007935639,0.00009924348,0.0000178391,0.001268898,0.0005359109,0.002205782,0.0001557467,0.001103733,0.0001849691],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962629,0.0001926428,0.000009886182,0.001890942,0.0005501701,0.0008338329,0.000005832143,0.00003289895,0.0002208681],"genre_scores_gemma":[0.9975965,0.0000778101,0.001820911,0.0003407134,0.00002757297,0.00004962349,0.00004369544,0.000008458123,0.0000346953],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05790015,"threshold_uncertainty_score":0.5418313,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3038254578","doi":"10.1002/cpdd.822","title":"Effect of Itraconazole, a Potent CYP3A4 Inhibitor, on the Steady‐State Pharmacokinetics of Vemurafenib in Patients With <i>BRAF</i><sup>V600</sup> Mutation–Positive Malignancies","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Roche (Canada)","funders":"","keywords":"Vemurafenib; Itraconazole; Medicine; Pharmacokinetics; Dosing; Pharmacology; Crossover study; Confidence interval; Area under the curve; Internal medicine; Adverse effect; Urology; Gastroenterology; Cancer; Dermatology; Pathology; Metastatic melanoma","authors":[{"name":"Weijiang Zhang","is_ca":false},{"name":"Michael S. Mathisen","is_ca":false},{"name":"Grant R. Goodman","is_ca":false},{"name":"Harper Forbes","is_ca":true},{"name":"Yuyao Song","is_ca":true},{"name":"Enric Bertran","is_ca":false},{"name":"Lev Demidov","is_ca":false},{"name":"Sang Joon Shin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01222371963840386,"gpt":0.2778418450221536,"spread":0.2656181253837497,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008611402,0.0002786057,0.0004925965,0.00007089526,0.00004037611,0.000005167812,0.0003098004,0.0001322292,0.00002590254],"category_scores_gemma":[0.0001549715,0.0001956392,0.00009695411,0.0002169915,0.0002751602,0.000006978342,0.000184267,0.0003592735,0.00001079717],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000329015,"about_ca_system_score_gemma":0.0002203577,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005391706,"about_ca_topic_score_gemma":0.000005666961,"domain_scores_codex":[0.9972196,0.0007135941,0.001010336,0.00047273,0.000261041,0.0003226777],"domain_scores_gemma":[0.9987492,0.0004842008,0.0003379342,0.0001528691,0.0001463516,0.0001294652],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.04003723,0.007356582,0.5949381,0.001108556,0.00198684,0.0004683764,0.01678299,0.02253914,0.2507949,0.00007469835,0.02202133,0.04189127],"study_design_scores_gemma":[0.0106411,0.003118777,0.09349313,0.00009746533,0.00006664481,0.000001728742,0.00008877293,0.000167542,0.8892707,0.000006454904,0.002752093,0.0002956446],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975774,0.00009887745,0.00002305323,0.0006951075,0.0002491959,0.001083023,0.00004758919,0.000007806079,0.0002180022],"genre_scores_gemma":[0.9967611,0.00006490888,0.0001687603,0.002624802,0.0001005637,0.0001117098,0.0001050797,0.00002426124,0.00003885577],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6384757,"threshold_uncertainty_score":0.7977934,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3119947423","doi":"10.1002/cpdd.901","title":"A Colon‐Targeted Adsorbent (DAV132) Does Not Affect the Pharmacokinetics of Warfarin or Clonazepam in Healthy Subjects","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Warfarin; Bioequivalence; Pharmacokinetics; Clonazepam; Crossover study; Pharmacology; Cmax; Concomitant; Pharmacodynamics; Drug; Internal medicine; Placebo","authors":[{"name":"Jean‐Louis Pinquier","is_ca":false},{"name":"Marina Varastet","is_ca":false},{"name":"D. E.R. Meyers","is_ca":false},{"name":"Sakina Sayah‐Jeanne","is_ca":false},{"name":"Céline Féger","is_ca":true},{"name":"Olivia Gaumétou","is_ca":false},{"name":"Tanguy Corbel","is_ca":false},{"name":"Jean de Gunzburg","is_ca":false},{"name":"France Mentré","is_ca":false},{"name":"Annie Ducher","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1668108786195618,"gpt":0.497394297777827,"spread":0.3305834191582652,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.007374962,0.000733546,0.001581251,0.0004160221,0.0002865223,0.00002474809,0.001218917,0.0007084848,0.00359998],"category_scores_gemma":[0.0007932244,0.0005184583,0.0003478282,0.001456699,0.0008758148,0.0001116144,0.0008958895,0.00333075,0.0001339822],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003266319,"about_ca_system_score_gemma":0.002653387,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006366416,"about_ca_topic_score_gemma":0.001050295,"domain_scores_codex":[0.9876144,0.005514704,0.003414445,0.00129643,0.000576121,0.00158392],"domain_scores_gemma":[0.9916986,0.005974254,0.0007728591,0.0004899555,0.0004027073,0.0006616903],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.04359557,0.02635776,0.3218071,0.001447844,0.003583274,0.006926825,0.01697269,0.007118163,0.3457869,0.0006311053,0.06103444,0.1647384],"study_design_scores_gemma":[0.01898567,0.000209113,0.09094456,0.00006750616,0.0003794765,0.00005115417,0.0003683756,0.002343084,0.5592449,0.0001884646,0.3263938,0.0008239147],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9711494,0.003923571,0.00001755385,0.009427566,0.01269726,0.001787098,0.00010396,0.00008392451,0.0008096063],"genre_scores_gemma":[0.9591717,0.01228309,0.001073725,0.02480564,0.0007109683,0.0005477852,0.00006338536,0.00007958112,0.001264101],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2653594,"threshold_uncertainty_score":0.9997267,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1904376711","doi":"10.1002/cpdd.27","title":"Impact of Tesamorelin, a Growth Hormone‐Releasing Factor (GRF) Analogue, on the Pharmacokinetics of Simvastatin and Ritonavir in Healthy Volunteers","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Adrenal Hormones and Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Theratechnologies (Canada)","funders":"","keywords":"Ritonavir; Simvastatin; Cmax; Medicine; Pharmacokinetics; Pharmacology; CYP3A; Crossover study; Regimen; Dosing; Internal medicine; Immunology; Placebo; Human immunodeficiency virus (HIV)","authors":[{"name":"Shirley Teng","is_ca":false},{"name":"Diane Potvin","is_ca":true},{"name":"Jean‐Claude Mamputu","is_ca":true},{"name":"Geneviève Vincent","is_ca":true},{"name":"Monika Zoltowska","is_ca":true},{"name":"Josée Morin","is_ca":true},{"name":"Saida Hatimi","is_ca":true},{"name":"Sophie‐Élise Michaud","is_ca":true},{"name":"Kim A. High","is_ca":true},{"name":"Murray P. Ducharme","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04274883741436251,"gpt":0.3949269658680695,"spread":0.3521781284537069,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004728362,0.0002402042,0.0007131992,0.0002369568,0.00003723159,0.000004228918,0.0001613066,0.0001297202,0.000210449],"category_scores_gemma":[0.0003860275,0.0001598089,0.0001305088,0.0003766534,0.0004180075,0.00005071658,0.0001048437,0.0006760358,0.00001516377],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001312283,"about_ca_system_score_gemma":0.0004368087,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006961104,"about_ca_topic_score_gemma":0.00003511902,"domain_scores_codex":[0.9973265,0.000271887,0.00141513,0.0003418291,0.0002426851,0.0004019602],"domain_scores_gemma":[0.9975857,0.001596634,0.0002973874,0.0001274476,0.0001687372,0.0002241519],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005402857,0.00379128,0.9251683,0.0002093627,0.0004653109,0.00005895744,0.003201142,0.0002125824,0.007916717,0.00003176372,0.02421241,0.02932926],"study_design_scores_gemma":[0.006302013,0.001039579,0.9892805,0.00008312155,0.00004250163,0.000005207841,0.0003671233,0.001687018,0.0008045143,0.00009204652,0.0001394639,0.0001568849],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949062,0.0007926921,0.00001610546,0.002965145,0.0001671713,0.0009903449,0.00001200123,0.00001195516,0.0001383108],"genre_scores_gemma":[0.994954,0.002085924,0.000657563,0.002131259,0.00005470419,0.00005897623,0.0000151709,0.00002102147,0.00002136297],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06411216,"threshold_uncertainty_score":0.6516818,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4409765779","doi":"10.1002/cpdd.1540","title":"Clinical Evaluation of Potential Interaction Between Bemnifosbuvir and Ruzasvir With an Assessment of Food Effect: Results of a Phase 1 Study in Healthy Participants","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Hepatitis C virus research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Altasciences (Canada)","funders":"","keywords":"NS5A; Medicine; Pharmacology; Drug; Adverse effect; Hepatitis C virus; NS5B; Combination therapy; Chronic hepatitis; Hepacivirus; Virus; Virology","authors":[{"name":"Xiao‐Jian Zhou","is_ca":false},{"name":"Gaetano Morelli","is_ca":true},{"name":"Maureen Montrond","is_ca":false},{"name":"Shannan Lynch","is_ca":false},{"name":"Keith Pietropaolo","is_ca":false},{"name":"Bruce Belanger","is_ca":false},{"name":"Arantxa Horga","is_ca":false},{"name":"Janet Hammond","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.217051315865395,"gpt":0.6195449109795277,"spread":0.4024935951141327,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02136715,0.0001702946,0.00121206,0.0004981431,0.00002879095,0.000003467744,0.0001516509,0.000167827,0.00003323487],"category_scores_gemma":[0.001361796,0.0001430757,0.00005908294,0.000491508,0.0003307775,0.00009208913,0.0001663863,0.0008013693,9.750649e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002532168,"about_ca_system_score_gemma":0.002376741,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001344405,"about_ca_topic_score_gemma":0.0007329248,"domain_scores_codex":[0.9904079,0.004555254,0.003397223,0.0005733296,0.0007308212,0.0003354305],"domain_scores_gemma":[0.9960812,0.002428875,0.0005869213,0.0002547577,0.0004387897,0.000209417],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01470522,0.01055432,0.8222257,0.0002093309,0.0005211825,0.00002273425,0.0007008087,0.00004961277,0.0003926499,0.000001104554,0.00007584112,0.1505415],"study_design_scores_gemma":[0.06641269,0.0162686,0.9080657,0.0002887444,0.0004451836,5.747779e-7,0.0002976278,0.004742673,0.003324633,0.00001716421,0.00004691264,0.00008946533],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.99577,0.00004096812,0.00004329029,0.0004145746,0.0003710559,0.003178191,0.00001585156,0.000008472171,0.0001576066],"genre_scores_gemma":[0.9985614,0.00007991244,0.0009052542,0.000103807,0.00005693829,0.0002356536,0.00003828848,0.00001130431,0.000007397294],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.150452,"threshold_uncertainty_score":0.7405471,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3095574760","doi":"10.1002/cpdd.884","title":"Bioequivalence of Metformin in Ertugliflozin/Metformin Fixed‐Dose Combination Tablets to Canadian‐Sourced Metformin Coadministered With Ertugliflozin Under Fasted and Fed States","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Metformin; Bioequivalence; Medicine; Crossover study; Pharmacology; Type 2 diabetes; Pharmacokinetics; Confidence interval; Diabetes mellitus; Internal medicine; Endocrinology; Placebo","authors":[{"name":"Vikas Kumar Dawra","is_ca":false},{"name":"Kathleen Pelletier","is_ca":false},{"name":"Kyle Matschke","is_ca":false},{"name":"Haihong Shi","is_ca":false},{"name":"Anne Hickman","is_ca":false},{"name":"Susan Zhou","is_ca":false},{"name":"Rajesh Krishna","is_ca":false},{"name":"Vaishali Sahasrabudhe","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05629632715691588,"gpt":0.3513404351448615,"spread":0.2950441079879456,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001242607,0.0004103376,0.001119119,0.0006206783,0.00006940143,0.00002030955,0.0002566283,0.0001700359,0.0001907422],"category_scores_gemma":[0.0002616874,0.0003401108,0.00006981022,0.0009015371,0.0002273013,0.0001726573,0.000233341,0.000387018,0.00004330974],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004935579,"about_ca_system_score_gemma":0.0009178395,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001424064,"about_ca_topic_score_gemma":0.01046594,"domain_scores_codex":[0.9965392,0.0002021694,0.001457305,0.0007198181,0.0003487316,0.0007327888],"domain_scores_gemma":[0.9978584,0.000634174,0.000270017,0.000201682,0.0001533399,0.0008823776],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02089367,0.009821299,0.5740121,0.002776529,0.005140921,0.004844727,0.03014837,0.001179525,0.008470632,0.0008667617,0.05046527,0.2913802],"study_design_scores_gemma":[0.1031566,0.0114143,0.6116032,0.001700769,0.001886526,0.00006551433,0.009129513,0.01070047,0.08372082,0.000432302,0.1631705,0.003019481],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.986352,0.0003051098,0.0001136655,0.01000048,0.000280628,0.002331641,0.00001978464,0.00004497349,0.0005517512],"genre_scores_gemma":[0.9819328,0.0003418579,0.005977796,0.01040568,0.00003969569,0.0003052665,0.0001607408,0.00004135858,0.0007948623],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2883607,"threshold_uncertainty_score":0.9999051,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3172814721","doi":"10.1002/cpdd.953","title":"Effects of Lemborexant on the Pharmacokinetics of Oral Contraceptives: Results From a Phase 1 Drug‐Drug Interaction Study in Healthy Females","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Sleep and Wakefulness Research","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Pharmacokinetics; Medicine; Drug; Tolerability; Pharmacology; Adverse effect; Drug interaction; Internal medicine","authors":[{"name":"Ishani Landry","is_ca":false},{"name":"Jagadeesh Aluri","is_ca":false},{"name":"Nancy Hall","is_ca":false},{"name":"Gleb Filippov","is_ca":false},{"name":"Satish Dayal","is_ca":false},{"name":"Margaret Moline","is_ca":false},{"name":"Larisa Reyderman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1643123047220055,"gpt":0.4857998073438024,"spread":0.3214875026217969,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002910133,0.0002515335,0.0007431237,0.0002367458,0.0000896487,0.0000147307,0.0005556028,0.00008031434,0.0001784823],"category_scores_gemma":[0.003168002,0.0001920748,0.0001029461,0.0007165702,0.0004234478,0.00008947873,0.0003374345,0.001152427,0.00002941693],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001574502,"about_ca_system_score_gemma":0.0005667558,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001880837,"about_ca_topic_score_gemma":0.0004600694,"domain_scores_codex":[0.9916118,0.004582807,0.001964327,0.0008333515,0.0005391592,0.0004685911],"domain_scores_gemma":[0.9795901,0.01937651,0.0004736524,0.0002665561,0.0001448526,0.000148342],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.08616585,0.1484128,0.09183491,0.0005330975,0.0008621186,0.004509585,0.09033997,0.001413135,0.4210906,0.0001476427,0.02716096,0.1275294],"study_design_scores_gemma":[0.0280488,0.0004591007,0.06346938,0.0001606097,0.00004483795,0.000001609932,0.002485609,0.0008217189,0.9024671,0.00005455603,0.00177638,0.0002102842],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930876,0.00009563073,0.000007734441,0.003127565,0.001862859,0.001603144,0.00004225177,0.0000180364,0.0001552016],"genre_scores_gemma":[0.997281,0.0003941,0.00009198459,0.001772407,0.00009296933,0.0002476196,0.0000119872,0.00001953514,0.00008836063],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4813765,"threshold_uncertainty_score":0.7832584,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2097275353","doi":"10.1002/cpdd.87","title":"Population pharmacokinetic analysis of dutogliptin, a selective dipeptidyl peptidase‐4 inhibitor","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Quebec Rehabilitation Research Network","funders":"","keywords":"Medicine; Dipeptidyl peptidase-4; Dipeptidyl peptidase-4 inhibitor; Pharmacokinetics; Pharmacology; Dipeptidyl peptidase; Population; Diabetes mellitus; Type 2 diabetes; Endocrinology; Biochemistry; Enzyme; Environmental health","authors":[{"name":"Jean‐Francois Marier","is_ca":true},{"name":"Samer Mouksassi","is_ca":true},{"name":"Nathalie Gosselin","is_ca":true},{"name":"Jianke Li","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02371763563722724,"gpt":0.3603088754721077,"spread":0.3365912398348805,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006883203,0.00025029,0.0009603513,0.0007576739,0.00004428859,0.000009134726,0.0001364267,0.0001160382,0.0016801],"category_scores_gemma":[0.00008475938,0.000218858,0.0002584293,0.001199176,0.0001196988,0.0001083221,0.0001415553,0.0003047666,0.0001891061],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002604532,"about_ca_system_score_gemma":0.0001132432,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009627559,"about_ca_topic_score_gemma":0.00004752638,"domain_scores_codex":[0.9972307,0.0002160873,0.0013507,0.0005114532,0.0002791973,0.0004118369],"domain_scores_gemma":[0.9987306,0.0003736163,0.0003101725,0.0001765788,0.000192426,0.0002166338],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002693319,0.003083185,0.9222848,0.0001040238,0.006207502,0.00003966348,0.0008870039,0.0002166396,0.003008054,0.00001550479,0.03232425,0.03156],"study_design_scores_gemma":[0.004662582,0.0001538203,0.9804217,0.00004661791,0.0027353,6.15048e-7,0.00007569616,0.001803735,0.006710583,0.00003982854,0.003142282,0.0002072983],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950907,0.00009989862,0.00002049742,0.0008747836,0.0006263619,0.001407507,0.000002882158,0.00006089499,0.001816482],"genre_scores_gemma":[0.9932932,0.00008189209,0.002226597,0.001708153,0.0001629921,0.0004214131,0.0001671622,0.00002066741,0.00191796],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0581368,"threshold_uncertainty_score":0.9992325,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2069868586","doi":"10.1002/cpdd.196","title":"Population pharmacokinetic modeling of motesanib and its active metabolite, M4, in cancer patients","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Quebec Rehabilitation Research Network","funders":"","keywords":"Medicine; Pharmacokinetics; Dosing; Covariate; Population; Demographics; Metabolite; Active metabolite; Internal medicine; Pharmacology; Oncology; Demography; Statistics; Environmental health","authors":[{"name":"Nathalie Gosselin","is_ca":true},{"name":"Samer Mouksassi","is_ca":true},{"name":"Jianfeng Lü","is_ca":false},{"name":"Cheng‐Pang Hsu","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1516378251483388,"gpt":0.4866974679411927,"spread":0.3350596427928539,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001368424,0.0001506221,0.0007845711,0.0002598189,0.0000231898,0.000002045427,0.00009774718,0.0001514042,0.00009980406],"category_scores_gemma":[0.0004510869,0.0001330548,0.00003577745,0.0002710088,0.00008802299,0.00008060593,0.0001306702,0.0004900533,0.000009710073],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002833764,"about_ca_system_score_gemma":0.0006165087,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002097299,"about_ca_topic_score_gemma":0.00006726811,"domain_scores_codex":[0.9976479,0.0003593641,0.001049172,0.0003442722,0.0002693081,0.0003299681],"domain_scores_gemma":[0.9988791,0.0003589696,0.0001524538,0.00006904557,0.000267526,0.0002728718],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001314249,0.001322857,0.9849939,0.00009338519,0.0001498415,0.00002551534,0.001572072,0.0005965036,0.000258734,0.000007723995,0.0003464604,0.00931872],"study_design_scores_gemma":[0.01284879,0.0001401483,0.9151419,0.0000932795,0.0001474035,0.000002011116,0.000113174,0.06976503,0.001177624,0.0001084449,0.0003265483,0.0001356602],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965584,0.0009700455,0.00001109505,0.0005698015,0.0005130304,0.0008565232,0.00000554363,0.00001164416,0.0005038664],"genre_scores_gemma":[0.9971134,0.0009898478,0.0008509437,0.0005895042,0.00009934858,0.000145755,0.00003049512,0.0000137221,0.0001669533],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06985205,"threshold_uncertainty_score":0.5425818,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4413114117","doi":"10.1002/cpdd.1583","title":"Safety, Tolerability, and Pharmacokinetics of the Long‐Acting SARS‐CoV‐2–Neutralizing Monoclonal Antibody Combination AZD7442 (Tixagevimab/Cilgavimab) in Healthy Chinese Adults","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Infection and Immunity","funders":"AstraZeneca","keywords":"Medicine; Tolerability; Coronavirus disease 2019 (COVID-19); Pharmacokinetics; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Virology; Monoclonal antibody; 2019-20 coronavirus outbreak; Pharmacology; Antibody; Immunology; Adverse effect; Internal medicine; Infectious disease (medical specialty); Outbreak; Disease","authors":[{"name":"Nanyang Li","is_ca":false},{"name":"Jing Zhang","is_ca":false},{"name":"Wenhong Zhang","is_ca":true},{"name":"Zhongyuan Xu","is_ca":false},{"name":"Xiangcao Yao","is_ca":false},{"name":"Anqi He","is_ca":false},{"name":"Shuyuan Liu","is_ca":false},{"name":"Xiaoyun Ge","is_ca":false},{"name":"Jinxi Liu","is_ca":false},{"name":"Yunfei Li","is_ca":false},{"name":"Cecil Chi‐Keung Chen","is_ca":false},{"name":"Huixia Zhang","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05256922252441759,"gpt":0.4732816387254207,"spread":0.4207124162010031,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003307702,0.0002912697,0.0008503192,0.0003703382,0.0001296228,0.00001485217,0.000395266,0.0002168262,0.00001627094],"category_scores_gemma":[0.0007711737,0.0002289059,0.0001324635,0.001006244,0.0004444358,0.00009280511,0.0006240891,0.001366497,0.000006746322],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004396097,"about_ca_system_score_gemma":0.001210467,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001896702,"about_ca_topic_score_gemma":0.0003329255,"domain_scores_codex":[0.9956741,0.0007271751,0.001975668,0.00066737,0.0003999408,0.0005557624],"domain_scores_gemma":[0.9973045,0.001861388,0.0002834489,0.0002551048,0.0002293218,0.00006624656],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003992257,0.002194966,0.95084,0.0007690903,0.0001019507,0.00006772682,0.001099692,0.00000783697,0.01575577,0.00002521123,0.0004131906,0.02473232],"study_design_scores_gemma":[0.01496235,0.000184362,0.9204794,0.0005218214,0.00005585085,0.00001125295,0.0001378014,0.001864083,0.05623908,0.000251014,0.005080281,0.000212697],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9876119,0.0006319882,0.00003688678,0.007927519,0.001378215,0.001508876,0.000004139378,0.00003112344,0.0008693778],"genre_scores_gemma":[0.9649537,0.0002024414,0.0003316411,0.03429744,0.0000893576,0.00007412441,0.000009566293,0.00001892112,0.00002283745],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04048331,"threshold_uncertainty_score":0.933451,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}